Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.4558578007380985e-16,7.067110299234517,254.01233543919886,"['RPL10', 'RPL34', 'RPL12', 'RPL11', 'RPL36A', 'RPL10A', 'RPL9', 'RPL6', 'RPS4X', 'RPL7A', 'RPS14', 'RPS15A', 'RPS19', 'RPS18', 'RPS3', 'RPL35', 'RPL38', 'RPL37', 'RPL15', 'RPS27A', 'RPL39', 'RPS10', 'RPL17', 'RPS13', 'RPL41', 'RPL21', 'RPS8', 'RPL23', 'RPL22', 'RPL35A', 'RPSA', 'RPS27', 'RPS29', 'RPL24', 'RPL27', 'FAU', 'RPL29', 'RPS24', 'RPS23']",5.746707253727151e-14,0,0,39
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.4558578007380985e-16,7.067110299234517,254.01233543919886,"['NDUFB6', 'COX4I1', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'SDHC', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'COX7A2L', 'SCO1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'SLC25A5']",5.746707253727151e-14,0,0,39
3,Oxidative phosphorylation WP623,1.2969005164593057e-08,6.02192439862543,109.36238377002624,"['ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFB6', 'NDUFA5', 'NDUFA2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME']",2.023164805676517e-06,0,0,21
4,Nonalcoholic fatty liver disease WP4396,2.9920130916075146e-07,3.0905029564201767,46.42599656172653,"['NDUFB6', 'COX4I1', 'NDUFB2', 'PIK3R3', 'NDUFB1', 'COX7A2', 'UQCR11', 'PIK3CB', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'NDUFV1', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'EIF2AK3', 'NDUFA1', 'NDUFC2', 'SDHC', 'NDUFC1', 'COX6C', 'EIF2S1', 'NFKB1', 'COX6B1', 'COX7A2L', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFAB1']",3.5006553171807924e-05,0,0,34
5,Mitochondrial complex I assembly model OXPHOS system WP4324,7.228402788015287e-06,4.418509979853366,52.304078574128155,"['NDUFA7', 'NDUFA6', 'DMAC1', 'NDUFB6', 'NDUFA5', 'ACAD9', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'TMEM126B', 'NDUFV1']",0.0006765785009582308,0,0,17
6,Mitochondrial CIV Assembly WP4922,0.0002686584757614741,4.478660815862181,36.823860906223985,"['TMEM177', 'COA3', 'PET100', 'COX4I1', 'COX7A2', 'COX14', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1']",0.02095536110939498,0,0,11
7,Mitochondrial complex III assembly WP4921,0.0004231360341881478,7.468771272974813,58.016047244368124,"['UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.028289666285721885,0,0,7
8,Cellular Proteostasis WP4918,0.0015396541845473146,17.04483695652174,110.38572951863887,"['PFDN1', 'PFDN2', 'PFDN4', 'PFDN6']",0.0900697697960179,0,0,4
9,Hippo-Yap signaling pathway WP4537,0.005985498550910082,4.651576994434137,23.808704454665374,"['YWHAQ', 'NF2', 'TNIK', 'NDRG1', 'TEAD1', 'MAP4K3']",0.31124592464732426,0,0,6
10,Chemokine signaling pathway WP3929,0.012842309484598144,1.8895069512058866,8.22882191413786,"['VAV3', 'PRKCD', 'PXN', 'PIK3R3', 'BRAF', 'PIK3CB', 'ADCY1', 'RASGRP2', 'ADCY7', 'NFKB1', 'NFKBIA', 'GNG3', 'RAP1A', 'PLCB4', 'GNB5', 'JAK2', 'SOS1', 'SOS2', 'CCL28']",0.5682751742356145,0,0,19
11,Pyrimidine metabolism WP4022,0.013356895120922562,2.0674637345167914,8.922599837643038,"['DUT', 'RRM2', 'POLR3GL', 'NME2', 'NME1', 'POLE4', 'POLR3D', 'TWISTNB', 'POLE3', 'TK2', 'POLE', 'DCTPP1', 'POLR3K', 'POLR2K', 'POLR2L']",0.5682751742356145,0,0,15
12,Regulation of Actin Cytoskeleton WP51,0.014615188178595546,1.7964742268041236,7.591350369957661,"['PXN', 'PIK3R3', 'BRK1', 'BRAF', 'PIK3C2G', 'ARPC5', 'PIK3CB', 'RHOA', 'ACTG1', 'GNA13', 'FGF14', 'MRAS', 'APC', 'ABI2', 'TMSB4X', 'PIP5K1B', 'SOS1', 'FGF12', 'SOS2', 'FGF22', 'ARHGEF6']",0.5699923389652263,0,0,21
13,Fatty Acid Biosynthesis WP357,0.018204438748095932,3.4100680272108845,13.661038834473189,"['MECR', 'ACSS2', 'ACSL6', 'ACACB', 'ACACA', 'DECR1']",0.6553597949314536,0,0,6
14,DNA Mismatch Repair WP531,0.022857936512459834,3.196683673469388,12.078531454323855,"['POLE4', 'RFC3', 'RFC2', 'POLE3', 'RPA1', 'POLE']",0.7002048343454234,0,0,6
15,Cytosolic DNA-sensing pathway WP4655,0.024337134550669142,2.3993481595092025,8.915382540740378,"['NFKBIA', 'POLR3GL', 'POLR3D', 'POLR2F', 'ISG15', 'POLR3K', 'POLR2K', 'NFKB1', 'POLR2L']",0.7002048343454234,0,0,9
16,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.02824783031798398,3.008403361344538,10.730188475233447,"['RAP1A', 'YWHAQ', 'LPL', 'NDRG1', 'TEAD1', 'RHOA']",0.7002048343454234,0,0,6
17,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.029424117366220488,6.386456211812627,22.51826539000002,"['TIFA', 'UBE2V1', 'NFKB1']",0.7002048343454234,0,0,3
18,Supression of HMGB1 mediated inflammation by THBD WP4479,0.029424117366220488,6.386456211812627,22.51826539000002,"['NFKBIA', 'HMGB1', 'NFKB1']",0.7002048343454234,0,0,3
19,DNA damage response (only ATM dependent) WP710,0.030893868539370494,1.8300088002346728,6.363302105518275,"['WNT10B', 'SMAD3', 'WNT5A', 'PIK3R3', 'PIK3C2G', 'PIK3CB', 'HMGB1', 'NFKB1', 'RHOA', 'CCND2', 'APC', 'CAT', 'SOS1', 'SOS2', 'PDK1']",0.7002048343454234,0,0,15
20,Base Excision Repair WP4752,0.032924070726743054,2.5947257821055434,8.857229451682993,"['POLE4', 'FEN1', 'PARP1', 'PARP2', 'POLE3', 'HMGB1', 'POLE']",0.7002048343454234,0,0,7
21,Translation Factors WP107,0.033252116423432274,2.132844474761255,7.259428075367023,"['EEF1B2', 'EEF1A1', 'EIF6', 'EIF3J', 'EIF4H', 'EIF2AK3', 'EIF2S2', 'EIF2S1', 'EIF4G3', 'EIF1']",0.7002048343454234,0,0,10
22,Globo Sphingolipid Metabolism WP1424,0.03420931186322131,3.2772054593944464,11.061411962646138,"['B3GALNT1', 'ST6GAL2', 'ST8SIA1', 'B3GALT5', 'ST6GALNAC3']",0.7002048343454234,0,0,5
23,Photodynamic therapy-induced unfolded protein response WP3613,0.03441177604689046,2.8410430839002268,9.572486828781372,"['XBP1', 'WARS', 'DNAJB11', 'EIF2AK3', 'PDIA6', 'HSP90B1']",0.7002048343454234,0,0,6
24,Ras signaling WP4223,0.04120999243025643,1.5669073819348922,4.996984402726786,"['PRKCG', 'RAB5C', 'RASGRF2', 'PLA2G4C', 'GAB1', 'PIK3R3', 'PLA2G4A', 'PIK3CB', 'RASGRP2', 'NFKB1', 'RHOA', 'IGF1R', 'AFDN', 'GNG3', 'RAP1A', 'MRAS', 'ABL2', 'CALM3', 'GNB5', 'SOS1', 'RAB5A', 'SOS2']",0.7821909100211142,0,0,22
25,Canonical and non-canonical Notch signaling WP3845,0.0425256832259993,3.042876565990094,9.608330286280633,"['JAG1', 'MAML2', 'NOTCH4', 'PSEN2', 'DLK2']",0.7821909100211142,0,0,5
26,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.04345505055672857,5.108757637474541,16.021207995945204,"['TIFA', 'UBE2V1', 'NFKB1']",0.7821909100211142,0,0,3
27,Phosphoinositides metabolism WP4971,0.04775671487914086,2.074282871828884,6.309212619544978,"['MTMR2', 'PIKFYVE', 'PLCB4', 'MTMR3', 'INPP5D', 'PIK3C2G', 'PIP5K1B', 'PIK3CB', 'SBF2']",0.8277830579051082,0,0,9
28,DNA Repair Pathways Full Network WP4946,0.05180415622924564,1.6012088477366255,4.740034368656714,"['FEN1', 'RFC3', 'PARP1', 'CENPX', 'PRKDC', 'RFC2', 'PARP2', 'REV1', 'RPA1', 'FANCC', 'HMGB1', 'GTF2H3', 'GTF2H5', 'POLE4', 'RAP1A', 'POLE3', 'REV3L', 'POLE']",0.8383692289726145,0,0,18
29,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.05195324425087671,2.8397915250396557,8.398431017309228,"['TTC9', 'PNCK', 'TPM3', 'NR3C1', 'JAK2']",0.8383692289726145,0,0,5
30,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.056598602027790434,1.538956538956539,4.4195307484226785,"['VAV3', 'CYFIP1', 'BDNF', 'PRKCD', 'CAMK2A', 'EIF2S2', 'ACACB', 'EIF2S1', 'NFKB1', 'PTPRF', 'NFKBIA', 'GRIP1', 'MARCKS', 'RAP1A', 'APC', 'DOK5', 'DPYSL2', 'CAMK4', 'JAK2', 'SH2B1']",0.8383692289726145,0,0,20
31,Alpha 6 Beta 4 signaling pathway WP244,0.05781434782794289,2.4345966958211855,6.939862438918181,"['LAMA3', 'PRKCD', 'GAB1', 'LAMC1', 'SOS1', 'RHOA']",0.8383692289726145,0,0,6
32,Genes targeted by miRNAs in adipocytes WP1992,0.06019674012526377,4.256958587915818,11.96263717114481,"['TMSB4X', 'PTBP2', 'KCNJ2']",0.8383692289726145,0,0,3
33,Glutathione metabolism WP100,0.06019674012526377,4.256958587915818,11.96263717114481,"['IDH1', 'GSS', 'GCLM']",0.8383692289726145,0,0,3
34,Pathogenic Escherichia coli infection WP2272,0.060907166207412156,2.066551069275865,5.783045686662509,"['TUBB2A', 'YWHAQ', 'ARPC3', 'ARPC5L', 'ARPC5', 'YWHAZ', 'RHOA', 'ACTG1']",0.8383692289726145,0,0,8
35,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.07415912372202656,2.5052985164154036,6.517639748514396,"['TGFBR3', 'SMAD3', 'APC', 'WNT5A', 'TGFA']",0.9375298139383003,0,0,5
36,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.07471922769876073,1.8713152775699535,4.854225178823933,"['MAP2K4', 'APC', 'TMSB4X', 'TGFA', 'SOS1', 'NEFH', 'RHOA', 'PFN2', 'SOD1']",0.9375298139383003,0,0,9
37,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.07687965245490476,1.948151031529778,4.998008813588268,"['SMAD3', 'TMEM43', 'BANF1', 'ADCY1', 'SOS1', 'ADCY7', 'SOS2', 'RHOA']",0.9375298139383003,0,0,8
38,TCA cycle in senescence WP5050,0.07945930112177914,3.6485306953738728,9.23994165339486,"['ME1', 'BRAF', 'PDK1']",0.9375298139383003,0,0,3
39,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.08485969839738129,1.6505817028027499,4.071582307876487,"['PRKCG', 'MRAS', 'GAB1', 'PIK3R3', 'TGFA', 'NRG1', 'BRAF', 'PIK3CB', 'JAK2', 'SOS1', 'SOS2', 'IGF1R']",0.9375298139383003,0,0,12
40,Nucleotide Excision Repair WP4753,0.08572171937171842,1.8938843475628218,4.652609184345508,"['POLE4', 'RFC3', 'RFC2', 'POLE3', 'RPA1', 'GTF2H3', 'POLE', 'GTF2H5']",0.9375298139383003,0,0,8
41,VEGFA-VEGFR2 Signaling Pathway WP3888,0.08693232698481204,1.2607540621825992,3.079549786712595,"['NAPA', 'YWHAE', 'EPB41', 'NOTCH4', 'PXN', 'ARPC5L', 'CRIP2', 'TXN', 'HMGB1', 'RPL10A', 'ACACB', 'NDRG1', 'SLC8A1', 'ACACA', 'CAMKK2', 'ACTG1', 'RAP1A', 'TMSB4X', 'DHX36', 'AP2S1', 'RICTOR', 'ASCC3', 'ATP6V1E1', 'ACP1', 'ZC3H15', 'DECR1', 'MAP2K4', 'JAG1', 'SDF2L1', 'TPM3', 'PRKCD', 'IDH2', 'EIF2AK3', 'GAB1', 'PLA2G4A', 'PDIA6', 'NFKB1', 'RHOA', 'DNAJA1', 'NFKBIA', 'INPP4B', 'AFDN', 'KATNAL2', 'RPL27', 'GRSF1', 'RAB5A', 'PTMA']",0.9375298139383003,0,0,47
42,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.08881881967728293,2.1297619047619047,5.156487343744339,"['PRKCG', 'PLCB4', 'PRKCD', 'PIK3CB', 'NFKB1', 'PDK1']",0.9375298139383003,0,0,6
43,Mitochondrial fatty acid synthesis pathway WP4317,0.08922340592292002,5.67345092718227,13.710528886135172,"['MECR', 'ACACA']",0.9375298139383003,0,0,2
44,ErbB signaling pathway WP673,0.09317246293977109,1.5838394688018749,3.758931062556652,"['PRKCG', 'MAP2K4', 'CAMK2A', 'GAB1', 'PIK3R3', 'TGFA', 'NRG1', 'BRAF', 'PIK3CB', 'NRG3', 'ABL2', 'SOS1', 'SOS2']",0.9375298139383003,0,0,13
45,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.09575043134076269,2.6199832775919734,6.146507351757078,"['RAB5C', 'MRAS', 'BRAF', 'RAB5A']",0.9375298139383003,0,0,4
46,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.09575043134076269,2.6199832775919734,6.146507351757078,"['EIF3J', 'EIF2S2', 'EIF2S1', 'EIF1']",0.9375298139383003,0,0,4
47,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.10072819681366217,2.241225088554152,5.144350085145577,"['FGD4', 'MTMR2', 'HSPB8', 'NDRG1', 'SBF2']",0.9375298139383003,0,0,5
48,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.10100648995214366,3.1922097759674135,7.318365985348715,"['CDK8', 'JAG1', 'H2AFY']",0.9375298139383003,0,0,3
49,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.10100648995214366,3.1922097759674135,7.318365985348715,"['ZEB1', 'JAK2', 'NFKB1']",0.9375298139383003,0,0,3
50,RAS and bradykinin pathways in COVID-19 WP4969,0.10100648995214366,3.1922097759674135,7.318365985348715,"['KLKB1', 'NFKB1', 'RHOA']",0.9375298139383003,0,0,3
51,Myometrial relaxation and contraction pathways WP289,0.10600611512225276,1.450301576422207,3.2548516356651045,"['PRKCG', 'YWHAE', 'RYR2', 'YWHAB', 'PRKCD', 'CAMK2A', 'ADCY1', 'YWHAZ', 'ADCY7', 'SLC8A1', 'NFKB1', 'ACTG1', 'RGS4', 'GNG3', 'YWHAQ', 'CALM3', 'GNB5']",0.9375298139383003,0,0,17
52,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.1133336183555519,2.4326475155279503,5.296893979158693,"['MDH2', 'IDH2', 'IDH3B', 'SDHC']",0.9375298139383003,0,0,4
53,Vitamin D in inflammatory diseases WP4482,0.1133336183555519,2.4326475155279503,5.296893979158693,"['NFKBIA', 'SMAD3', 'NR3C1', 'NFKB1']",0.9375298139383003,0,0,4
54,MET in type 1 papillary renal cell carcinoma WP4205,0.11934537441979114,1.6672445985596158,3.5441180015928153,"['RAP1A', 'PRCC', 'RPL11', 'GAB1', 'PIK3R3', 'BRAF', 'PIK3CB', 'SOS1', 'SOS2']",0.9375298139383003,0,0,9
55,Cell cycle WP179,0.12241110738378153,1.4737464322507643,3.095413039169796,"['YWHAE', 'CDKN2D', 'SMAD3', 'GADD45B', 'PRKDC', 'YWHAB', 'YWHAZ', 'ANAPC11', 'STAG1', 'CCND2', 'CDC23', 'YWHAQ', 'TFDP2', 'MCM6']",0.9375298139383003,0,0,14
56,ACE Inhibitor Pathway WP554,0.12472259916932926,4.254748982360923,8.856954443143799,"['MAS1', 'NR3C2']",0.9375298139383003,0,0,2
57,Nephrogenesis WP5052,0.12472259916932926,4.254748982360923,8.856954443143799,"['JAG1', 'GREB1L']",0.9375298139383003,0,0,2
58,Pilocytic astrocytoma WP2253,0.12472259916932926,4.254748982360923,8.856954443143799,"['BRAF', 'SOS1']",0.9375298139383003,0,0,2
59,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.12472259916932926,4.254748982360923,8.856954443143799,"['NFKBIA', 'NFKB1']",0.9375298139383003,0,0,2
60,Serotonin Transporter Activity WP1455,0.12472259916932926,4.254748982360923,8.856954443143799,"['PPP2CB', 'STX1A']",0.9375298139383003,0,0,2
61,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.12722219010659488,1.8926681783824642,3.9023414683970548,"['MAP1LC3A', 'SMAD3', 'RICTOR', 'NFKB1', 'IGF1R', 'PDK1']",0.9375298139383003,0,0,6
62,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.12722219010659488,1.8926681783824642,3.9023414683970548,"['BDNF', 'GABRA3', 'PIK3R3', 'PIK3CB', 'JAK2', 'RHOA']",0.9375298139383003,0,0,6
63,Ciliary landscape WP4352,0.1282484842193419,1.3054847870182555,2.6811858748133757,"['CAMK2A', 'COPS7A', 'RPGR', 'PSMD8', 'PSMD7', 'PGRMC2', 'ARHGDIA', 'BBS9', 'CEP170', 'SNRPB2', 'DCAF11', 'RAB2A', 'NDUFA5', 'H3F3A', 'EXOC6B', 'DYNLL1', 'COX6C', 'LSM4', 'NFKB1', 'COPS4', 'IFT20', 'TBC1D4', 'RAB14', 'APC', 'WNK1', 'MCM6']",0.9375298139383003,0,0,26
64,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.13221574299129876,2.270289855072464,4.593523491625236,"['EDA', 'CCND2', 'WNT5A', 'NFKB1']",0.9375298139383003,0,0,4
65,Nucleotide metabolism WP404,0.13221574299129876,2.270289855072464,4.593523491625236,"['RRM2', 'NME2', 'OAZ1', 'SRM']",0.9375298139383003,0,0,4
66,Striated Muscle Contraction Pathway WP383,0.13221574299129876,2.270289855072464,4.593523491625236,"['TPM4', 'TPM3', 'TPM1', 'ACTG1']",0.9375298139383003,0,0,4
67,B Cell Receptor Signaling Pathway WP23,0.14146568087287803,1.5120004403831333,2.9570164327834783,"['NFKBIA', 'PTPN18', 'INPP5D', 'PRKCD', 'CAMK2A', 'GAB1', 'PIP5K1B', 'BRAF', 'SOS1', 'MEF2D', 'NFKB1']",0.9541096371653323,0,0,11
68,Proximal tubule transport WP4917,0.14155335764940363,1.824927113702624,3.5678758500509424,"['ATP6V1G1', 'SLC22A6', 'SLC47A1', 'ATP6V1E1', 'SLC22A8', 'ATP6V1F']",0.9541096371653323,0,0,6
69,Fatty acid transporters WP5061,0.1498806607354735,2.5533604887983707,4.846063461533888,"['FABP5', 'FABP7', 'ACSL6']",0.9541096371653323,0,0,3
70,miRNA targets in ECM and membrane receptors WP2911,0.1498806607354735,2.5533604887983707,4.846063461533888,"['COL6A1', 'COL5A2', 'LAMC1']",0.9541096371653323,0,0,3
71,Non-small cell lung cancer WP4255,0.15196522431418974,1.521511401286299,2.8666850655736895,"['PRKCG', 'GADD45B', 'PIK3R3', 'TGFA', 'BRAF', 'PIK3CB', 'SOS1', 'SOS2', 'FHIT', 'PDK1']",0.9541096371653323,0,0,10
72,EPO Receptor Signaling WP581,0.15228137477738515,2.128226902173913,4.005376915640851,"['PTPRU', 'JAK2', 'SOS1', 'PDK1']",0.9541096371653323,0,0,4
73,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.15228137477738515,2.128226902173913,4.005376915640851,"['NFKBIA', 'DYRK1A', 'NFKB1', 'PDK1']",0.9541096371653323,0,0,4
74,Fas ligand pathway and stress induction of heat shock proteins WP314,0.15658981476792866,1.7618578465869106,3.2667056265138843,"['MAP2K4', 'PARP1', 'PRKDC', 'CASP6', 'ACTG1', 'LMNB1']",0.9541096371653323,0,0,6
75,IL-6 signaling pathway WP364,0.15658981476792866,1.7618578465869106,3.2667056265138843,"['NCOA1', 'MAP2K4', 'PRKCD', 'GAB1', 'JAK2', 'SOS1']",0.9541096371653323,0,0,6
76,Aspirin and miRNAs WP4707,0.162842011757921,3.403527815468114,6.177317220338622,"['NFKB1', 'PDK1']",0.9541096371653323,0,0,2
77,"Cerebral organic acidurias, including diseases WP4519",0.162842011757921,3.403527815468114,6.177317220338622,"['MDH2', 'IDH2']",0.9541096371653323,0,0,2
78,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.162842011757921,3.403527815468114,6.177317220338622,"['CCND2', 'MEF2D']",0.9541096371653323,0,0,2
79,AGE/RAGE pathway WP2324,0.16302214273836158,1.5846904505417907,2.874421266932407,"['NFKBIA', 'SMAD3', 'PRKCD', 'PLA2G4A', 'JAK2', 'RHOA', 'NFKB1', 'SOD1']",0.9541096371653323,0,0,8
80,Calcium Regulation in the Cardiac Cell WP536,0.17494482438287484,1.3370937416062316,2.330934987348619,"['PRKCG', 'YWHAE', 'RYR2', 'YWHAB', 'PRKCD', 'CAMK2A', 'ADCY1', 'YWHAZ', 'ADCY7', 'SLC8A1', 'RGS4', 'GNG3', 'YWHAQ', 'CAMK4', 'CALM3', 'GNB5']",0.9541096371653323,0,0,16
81,MAPK pathway in congenital thyroid cancer WP4928,0.17664462221452124,2.321051657100537,4.023810778124678,"['BRAF', 'SOS1', 'SOS2']",0.9541096371653323,0,0,3
82,Common Pathways Underlying Drug Addiction WP2636,0.188603846464162,1.647926267281106,2.748916541315005,"['PRKCG', 'RAP1A', 'CAMK4', 'CAMK2A', 'ADCY1', 'ACTG1']",0.9541096371653323,0,0,6
83,Aflatoxin B1 metabolism WP699,0.19943890968736497,8.505762711864406,13.713393023226018,['AKR7A2'],0.9541096371653323,0,0,1
84,Nanomaterial-induced inflammasome activation WP3890,0.19943890968736497,8.505762711864406,13.713393023226018,['NFKB1'],0.9541096371653323,0,0,1
85,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.20263767747890987,2.8360470375395748,4.527283231230767,"['JAG1', 'VHL']",0.9541096371653323,0,0,2
86,Canonical NF-KB pathway WP4562,0.20263767747890987,2.8360470375395748,4.527283231230767,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
87,Mitochondrial CII Assembly WP4920,0.20263767747890987,2.8360470375395748,4.527283231230767,"['SDHAF1', 'SDHC']",0.9541096371653323,0,0,2
88,MAPK Cascade WP422,0.2030221338393457,1.7025152957171992,2.714558951515621,"['MAP2K4', 'MAP2', 'BRAF', 'SOS1', 'SOS2']",0.9541096371653323,0,0,5
89,Neural Crest Cell Migration during Development WP4564,0.2030221338393457,1.7025152957171992,2.714558951515621,"['BDNF', 'PIK3R3', 'PIK3CB', 'RHOA', 'NGEF']",0.9541096371653323,0,0,5
90,PDGF Pathway WP2526,0.20548538527007335,1.5963010204081634,2.5259553920928095,"['NFKBIA', 'MAP2K4', 'PLA2G4A', 'SOS1', 'NFKB1', 'RHOA']",0.9541096371653323,0,0,6
91,Corticotropin-releasing hormone signaling pathway WP2355,0.21003471698391363,1.3962382304922505,2.1788052448689617,"['NFKBIA', 'NCOA2', 'PARP1', 'PRKCD', 'CAMK2A', 'BRAF', 'GNB5', 'RHOA', 'ACACA', 'NFKB1']",0.9541096371653323,0,0,10
92,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.21235192504057052,1.3107439755866568,2.0310113653507695,"['MAP2K4', 'WNT10B', 'SMAD3', 'JAG1', 'PDCD6', 'NOTCH4', 'WNT5A', 'PIK3R3', 'PIK3CB', 'ZEB1', 'FMNL2', 'SOS1', 'SOS2', 'MEF2D']",0.9541096371653323,0,0,14
93,BDNF-TrkB Signaling WP3676,0.22267556192503313,1.6369032055639805,2.4586931842806092,"['BDNF', 'GAB1', 'BRAF', 'ADCY1', 'SOS1']",0.9541096371653323,0,0,5
94,Regulation of Microtubule Cytoskeleton WP2038,0.22288141358715857,1.5478045763760049,2.3234333269631207,"['CLIP1', 'APC', 'DPYSL2', 'CAMK4', 'STMN1', 'TESK2']",0.9541096371653323,0,0,6
95,7q11.23 copy number variation syndrome WP4932,0.2236589020395829,1.3274430487545241,1.9880227098452612,"['GRIP1', 'DNAJC30', 'RFC2', 'ATP5MC2', 'EIF2AK3', 'EIF4H', 'NRG1', 'ACACB', 'STX1A', 'ACACA', 'ATP5F1E', 'ATP5MC1']",0.9541096371653323,0,0,12
96,Microglia Pathogen Phagocytosis Pathway WP3937,0.23343604391777453,1.963653454488485,2.8568156146529837,"['VAV3', 'PIK3R3', 'PIK3CB']",0.9541096371653323,0,0,3
97,Pregnane X receptor pathway WP2876,0.23343604391777453,1.963653454488485,2.8568156146529837,"['NCOA1', 'NCOA2', 'DNAJC7']",0.9541096371653323,0,0,3
98,Pathways Regulating Hippo Signaling WP4540,0.23551487587460376,1.3516966586543666,1.9545279569561411,"['PRKCG', 'SMAD3', 'PLCB4', 'PRKCD', 'NF2', 'TEAD1', 'RHOA', 'CDH18', 'IGF1R', 'CDH7']",0.9541096371653323,0,0,10
99,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.23706218341454185,1.4534858622922513,2.092195217231035,"['PRKCG', 'IFI27L2', 'PLCB4', 'PRKCD', 'CAMK2A', 'ISG15', 'NFKB1']",0.9541096371653323,0,0,7
100,16p11.2 proximal deletion syndrome WP4949,0.24157239795103488,1.3684268185801929,1.943968071280398,"['IGBP1', 'PPP2CB', 'UNC13A', 'KCTD13', 'NR3C1', 'CDIPT', 'CORO1A', 'NFKB1', 'CCT4']",0.9541096371653323,0,0,9
101,Cell migration and invasion through p75NTR WP4561,0.24183103594576444,1.702038043478261,2.4160702272427796,"['EFNB3', 'BDNF', 'EFNA5', 'RHOA']",0.9541096371653323,0,0,4
102,Neovascularisation processes WP4331,0.24183103594576444,1.702038043478261,2.4160702272427796,"['SMAD3', 'JAG1', 'NOTCH4', 'NFKB1']",0.9541096371653323,0,0,4
103,Disruption of postsynaptic signaling by CNV WP4875,0.24286831315409205,1.5761512702369262,2.2306258673182358,"['RPH3A', 'RYR2', 'CYFIP1', 'CAMK2A', 'STX1A']",0.9541096371653323,0,0,5
104,Biotin Metabolism (including IEMs) WP5031,0.24333509354666924,2.4307036247334755,3.435351837419645,"['ACACB', 'ACACA']",0.9541096371653323,0,0,2
105,Cancer immunotherapy by CTLA4 blockade WP4582,0.24333509354666924,2.4307036247334755,3.435351837419645,"['PIK3R3', 'PIK3CB']",0.9541096371653323,0,0,2
106,Cytosine methylation WP3585,0.24333509354666924,2.4307036247334755,3.435351837419645,"['IDH1', 'IDH2']",0.9541096371653323,0,0,2
107,miR-509-3p alteration of YAP1/ECM axis WP3967,0.24333509354666924,2.4307036247334755,3.435351837419645,"['GPC6', 'TEAD1']",0.9541096371653323,0,0,2
108,Purine metabolism WP4792,0.24333509354666924,2.4307036247334755,3.435351837419645,"['DGUOK', 'APRT']",0.9541096371653323,0,0,2
109,Fragile X Syndrome  WP4549,0.2472385776992564,1.252667391391875,1.7504793004012238,"['CYFIP1', 'KCNC1', 'BDNF', 'CAMK2A', 'GAB1', 'BRAF', 'PIK3CB', 'AKAP5', 'EEF1A1', 'GRIP1', 'ALDH5A1', 'CAMK4', 'AP2S1', 'SOS1', 'PDK1']",0.9541096371653323,0,0,15
110,mRNA Processing WP411,0.250064400422446,1.2390535491905355,1.7173738071843114,"['SF3B5', 'SNRPN', 'DHX8', 'HNRNPR', 'SNU13', 'PTBP2', 'LSM2', 'PHF5A', 'SNRPD1', 'SNRPE', 'SNRPB2', 'SNRPF', 'SREK1', 'TXNL4A', 'HNRNPA1', 'SNRPB']",0.9541096371653323,0,0,16
111,Constitutive Androstane Receptor Pathway WP2875,0.2629401042250122,1.823247017748036,2.435546264776146,"['NCOA1', 'NCOA2', 'DNAJC7']",0.9541096371653323,0,0,3
112,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.2629401042250122,1.823247017748036,2.435546264776146,"['TGFBR3', 'SMAD3', 'LTBP1']",0.9541096371653323,0,0,3
113,Triacylglyceride synthesis WP325,0.2629401042250122,1.823247017748036,2.435546264776146,"['DGAT2', 'LPL', 'PLPP1']",0.9541096371653323,0,0,3
114,Amyotrophic lateral sclerosis (ALS) WP2447,0.26351940607600405,1.5197387588618043,2.0267665663090035,"['ALS2', 'CAT', 'NEFH', 'RAB5A', 'SOD1']",0.9541096371653323,0,0,5
115,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.26351940607600405,1.5197387588618043,2.0267665663090035,"['YWHAQ', 'NF2', 'TEAD1', 'MAP4K3', 'ACTG1']",0.9541096371653323,0,0,5
116,Neural Crest Cell Migration in Cancer WP4565,0.26351940607600405,1.5197387588618043,2.0267665663090035,"['BDNF', 'PIK3R3', 'PIK3CB', 'RHOA', 'NGEF']",0.9541096371653323,0,0,5
117,Resistin as a regulator of inflammation WP4481,0.26588167151983544,1.6208592132505175,2.1471585423499757,"['NFKBIA', 'PLCB4', 'PIK3CB', 'NFKB1']",0.9541096371653323,0,0,4
118,Leptin signaling pathway WP2034,0.270128667870685,1.3210281362386291,1.7290367724875841,"['NCOA1', 'KHDRBS1', 'JAK2', 'SOS1', 'ACACB', 'RHOA', 'ACACA', 'NFKB1', 'SH2B1']",0.9541096371653323,0,0,9
119,Selenium Micronutrient Network WP15,0.270305735883016,1.385660233982934,1.8127229427628584,"['SELENOM', 'CAT', 'SELENOW', 'TXN', 'NFKB1', 'SELENOH', 'SOD1']",0.9541096371653323,0,0,7
120,Wnt signaling WP428,0.2756890936369365,1.2899458431518458,1.6620713814008137,"['PRKCG', 'WNT10B', 'CCND2', 'PLCB4', 'APC', 'WNT5A', 'CAMK2A', 'PRICKLE2', 'DKK2', 'RHOA']",0.9541096371653323,0,0,10
121,GABA metabolism (aka GHB) WP4157,0.2837143996505802,4.252542372881356,5.357298371605529,['AKR7A2'],0.9541096371653323,0,0,1
122,Hypothetical Craniofacial Development Pathway WP3655,0.2837143996505802,4.252542372881356,5.357298371605529,['RHOA'],0.9541096371653323,0,0,1
123,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.2837143996505802,4.252542372881356,5.357298371605529,['MAS1'],0.9541096371653323,0,0,1
124,Dopamine metabolism WP2436,0.2843040416230922,2.126696065128901,2.6747691291435114,"['PPP2CB', 'SOD1']",0.9541096371653323,0,0,2
125,Nanoparticle triggered regulated necrosis WP2513,0.2843040416230922,2.126696065128901,2.6747691291435114,"['PARP1', 'PLA2G4A']",0.9541096371653323,0,0,2
126,DNA Replication WP466,0.2845480336867786,1.467216765512553,1.8440760930086737,"['RFC3', 'RFC2', 'RPA1', 'MCM6', 'POLE']",0.9541096371653323,0,0,5
127,Ferroptosis WP4313,0.2845480336867786,1.467216765512553,1.8440760930086737,"['MAP1LC3A', 'GSS', 'LPCAT3', 'ACSL6', 'GCLM']",0.9541096371653323,0,0,5
128,Nephrotic syndrome WP4758,0.2845480336867786,1.467216765512553,1.8440760930086737,"['CUBN', 'INF2', 'ARHGDIA', 'TTC21B', 'PDSS2']",0.9541096371653323,0,0,5
129,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.29286139958091467,1.701561439239647,2.0896124300028514,"['H3F3B', 'H2AFY', 'H3F3A']",0.9541096371653323,0,0,3
130,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.29286139958091467,1.701561439239647,2.0896124300028514,"['B3GALNT1', 'SGPL1', 'ST6GALNAC3']",0.9541096371653323,0,0,3
131,Monoamine Transport WP727,0.29286139958091467,1.701561439239647,2.0896124300028514,"['PPP2CB', 'AMPH', 'STX1A']",0.9541096371653323,0,0,3
132,NAD+ biosynthetic pathways WP3645,0.29286139958091467,1.701561439239647,2.0896124300028514,"['PARP1', 'TNKS', 'PARP2']",0.9541096371653323,0,0,3
133,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.29286139958091467,1.701561439239647,2.0896124300028514,"['RAP1A', 'BRAF', 'NR3C1']",0.9541096371653323,0,0,3
134,Melanoma WP4685,0.2944118296731138,1.3094739048417523,1.6011928845327095,"['GADD45B', 'PIK3R3', 'MITF', 'BRAF', 'CALM3', 'PIK3CB', 'SOS1', 'SOS2']",0.9541096371653323,0,0,8
135,IL-3 signaling pathway WP286,0.3058744011410987,1.4181962383865852,1.6799679141863981,"['YWHAQ', 'YWHAB', 'INPP5D', 'JAK2', 'SOS1']",0.9541096371653323,0,0,5
136,Ciliopathies WP4803,0.3139267672934283,1.1556672222766937,1.3389508957584428,"['TUB', 'DNAH11', 'ARL3', 'DCDC2', 'CFAP410', 'AHI1', 'CFAP298', 'RSPH1', 'TMEM17', 'CSPP1', 'TTC21B', 'TMEM216', 'TMEM107', 'SPAG1', 'NEK1', 'BBS9', 'B9D1', 'CCNO', 'DNAL1']",0.9541096371653323,0,0,19
137,Joubert Syndrome WP4656,0.314650448305879,1.255757819571558,1.4520239064370863,"['AHI1', 'TMEM17', 'PARP1', 'CSPP1', 'TMEM216', 'ARL3', 'BBS9', 'B9D1', 'RHOA']",0.9541096371653323,0,0,9
138,Retinoblastoma gene in cancer WP2446,0.314650448305879,1.255757819571558,1.4520239064370863,"['RFC3', 'RRM2', 'TFDP2', 'PRKDC', 'STMN1', 'RPA1', 'HMGB1', 'MCM6', 'POLE']",0.9541096371653323,0,0,9
139,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3150767473497376,1.479678638941399,1.7089386082010247,"['PIK3R3', 'RICTOR', 'PIK3CB', 'PDK1']",0.9541096371653323,0,0,4
140,Prostaglandin Synthesis and Regulation WP98,0.3150767473497376,1.479678638941399,1.7089386082010247,"['HSD11B2', 'S100A6', 'PLA2G4A', 'MITF']",0.9541096371653323,0,0,4
141,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3156618590277738,1.343609022556391,1.549293669387991,"['XBP1', 'MAP1LC3A', 'PPP1R3B', 'PPP1R7', 'EIF2AK3', 'EIF2S1']",0.9541096371653323,0,0,6
142,Glucocorticoid Receptor Pathway WP2880,0.3156618590277738,1.343609022556391,1.549293669387991,"['TGFBR3', 'FGD4', 'GADD45B', 'PLK2', 'PTGES3', 'NR3C1']",0.9541096371653323,0,0,6
143,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.3156618590277738,1.343609022556391,1.549293669387991,"['MAP2K4', 'PRKCD', 'PIK3R3', 'PIK3CB', 'EIF4G3', 'PDK1']",0.9541096371653323,0,0,6
144,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.32298245623815397,1.5950865580448066,1.8026986735011814,"['ACACB', 'ACACA', 'PDK1']",0.9541096371653323,0,0,3
145,Ovarian infertility WP34,0.32298245623815397,1.5950865580448066,1.8026986735011814,"['CCND2', 'SMAD3', 'MSH5']",0.9541096371653323,0,0,3
146,TLR4 Signaling and Tolerance WP3851,0.32298245623815397,1.5950865580448066,1.8026986735011814,"['NFKBIA', 'INPP5D', 'NFKB1']",0.9541096371653323,0,0,3
147,Hepatitis B infection WP4666,0.3235068056705963,1.1800192331134618,1.3316931558603498,"['PRKCG', 'MAP2K4', 'SMAD3', 'YWHAB', 'PIK3R3', 'BRAF', 'PIK3CB', 'YWHAZ', 'NFKB1', 'YWHAQ', 'STAT4', 'JAK2', 'SOS1', 'SOS2']",0.9541096371653323,0,0,14
148,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3250368262932253,1.8902457409920097,2.1242899035995713,"['RPH3A', 'EXPH5']",0.9541096371653323,0,0,2
149,Leptin Insulin Overlap WP3935,0.3250368262932253,1.8902457409920097,2.1242899035995713,"['PIK3R3', 'JAK2']",0.9541096371653323,0,0,2
150,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3250368262932253,1.8902457409920097,2.1242899035995713,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
151,"NAD metabolism, sirtuins and aging WP3630",0.3250368262932253,1.8902457409920097,2.1242899035995713,"['PARP1', 'NFKB1']",0.9541096371653323,0,0,2
152,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.3250368262932253,1.8902457409920097,2.1242899035995713,"['STAG1', 'ANAPC11']",0.9541096371653323,0,0,2
153,Complement system WP2806,0.327420461938512,1.3723383259139055,1.532229625808237,"['FKBP2', 'RPS19', 'TXN', 'LAMC1', 'KLKB1']",0.9541096371653323,0,0,5
154,Pancreatic adenocarcinoma pathway WP4263,0.3320304571927882,1.215844864548821,1.3405037068328696,"['SMAD3', 'GADD45B', 'PRKCD', 'PIK3R3', 'TGFA', 'BRAF', 'PIK3CB', 'RHOA', 'NFKB1', 'ARHGEF6']",0.9541096371653323,0,0,10
155,Prion disease pathway WP3995,0.33998081502656213,1.4179121376811594,1.5297373230310785,"['PDIA3', 'CHD2', 'NFKB1', 'HSP90B1']",0.9541096371653323,0,0,4
156,Prolactin Signaling Pathway WP2037,0.3430625743905735,1.2377508050532573,1.3241983114729938,"['NFKBIA', 'PXN', 'PIK3CB', 'JAK2', 'SOS1', 'PPIB', 'YWHAZ', 'NFKB1']",0.9541096371653323,0,0,8
157,G Protein Signaling Pathways WP35,0.346467284296803,1.1986242145917798,1.270501971938341,"['PRKCG', 'GNA13', 'GNG3', 'PDE4C', 'PRKCD', 'AKAP5', 'ADCY1', 'GNB5', 'ADCY7', 'RHOA']",0.9541096371653323,0,0,10
158,Gastrin signaling pathway WP4659,0.34722460547335315,1.1850174968678446,1.2534918729305515,"['NFKBIA', 'JAG1', 'CCKBR', 'PRKCD', 'PXN', 'PIK3R3', 'JAK2', 'SOS1', 'MEF2D', 'NFKB1', 'RHOA']",0.9541096371653323,0,0,11
159,Breast cancer pathway WP4262,0.34759499296217805,1.1647012267510883,1.2307599243314484,"['NCOA1', 'WNT10B', 'GADD45B', 'PARP1', 'NOTCH4', 'WNT5A', 'PIK3R3', 'BRAF', 'IGF1R', 'APC', 'SOS1', 'SOS2', 'FGF22']",0.9541096371653323,0,0,13
160,PKC-gamma calcium signaling pathway in ataxia WP4760,0.3531061706061932,1.5011381334611238,1.5626645325893946,"['PRKCG', 'PLCB4', 'PDK1']",0.9541096371653323,0,0,3
161,Vitamin B12 metabolism WP1533,0.3531061706061932,1.5011381334611238,1.5626645325893946,"['CUBN', 'NFKB1', 'SOD1']",0.9541096371653323,0,0,3
162,Oncostatin M Signaling Pathway WP2374,0.3576500953814132,1.24082425686408,1.2758156966334309,"['NFKBIA', 'PRKCD', 'PXN', 'RICTOR', 'JAK2', 'SOS1', 'NFKB1']",0.9541096371653323,0,0,7
163,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.35912353378363937,2.8348022598870055,2.9030893705367355,['NFKB1'],0.9541096371653323,0,0,1
164,Composition of Lipid Particles WP3601,0.35912353378363937,2.8348022598870055,2.9030893705367355,['LPL'],0.9541096371653323,0,0,1
165,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.35912353378363937,2.8348022598870055,2.9030893705367355,['GSS'],0.9541096371653323,0,0,1
166,"Phase I biotransformations, non P450 WP136",0.35912353378363937,2.8348022598870055,2.9030893705367355,['ESD'],0.9541096371653323,0,0,1
167,Role of Osx and miRNAs in tooth development WP3971,0.35912353378363937,2.8348022598870055,2.9030893705367355,['NOTCH4'],0.9541096371653323,0,0,1
168,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.35912353378363937,2.8348022598870055,2.9030893705367355,['CCKBR'],0.9541096371653323,0,0,1
169,Genes related to primary cilium development (based on CRISPR) WP4536,0.3607008842149137,1.1604880774962743,1.1833569337084482,"['IFT20', 'TMEM17', 'KIF3B', 'ARL3', 'TTC21B', 'TMEM216', 'TMEM107', 'BBS9', 'B9D1', 'KIFAP3', 'DYNLL1', 'TXNDC15']",0.9541096371653323,0,0,12
170,Melatonin metabolism and effects WP3298,0.36493962051712503,1.3610869565217392,1.3720074503288358,"['MAP2', 'CAMK2A', 'CRY2', 'NFKB1']",0.9541096371653323,0,0,4
171,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3651294918253542,1.7010854816824965,1.7138490938128663,"['RYR2', 'CCKBR']",0.9541096371653323,0,0,2
172,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3651294918253542,1.7010854816824965,1.7138490938128663,"['CD63', 'SOD1']",0.9541096371653323,0,0,2
173,Ganglio Sphingolipid Metabolism WP1423,0.3651294918253542,1.7010854816824965,1.7138490938128663,"['ST8SIA1', 'ST3GAL5']",0.9541096371653323,0,0,2
174,Major receptors targeted by epinephrine and norepinephrine WP4589,0.3651294918253542,1.7010854816824965,1.7138490938128663,"['ADCY1', 'ADCY7']",0.9541096371653323,0,0,2
175,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.3651294918253542,1.7010854816824965,1.7138490938128663,"['APC', 'TNKS']",0.9541096371653323,0,0,2
176,Endoderm differentiation WP2853,0.3739060682970641,1.1473567876220299,1.128713005566854,"['VAV3', 'SMAD3', 'APC', 'SESN1', 'TCEAL2', 'RTF1', 'LAMC1', 'ASCC3', 'NR3C1', 'JARID2', 'ACACA', 'NME1']",0.9541096371653323,0,0,12
177,Rett syndrome causing genes WP4312,0.3739781795165933,1.244997511199602,1.2245270464970683,"['SCN8A', 'GABRA3', 'BRAF', 'HAP1', 'RHOBTB2', 'SCN1A']",0.9541096371653323,0,0,6
178,Osteoblast differentiation WP4787,0.37560965134296415,1.165598310564578,1.141359502744426,"['PRKCG', 'WNT10B', 'JAG1', 'PRKDC', 'NOTCH4', 'WNT5A', 'PRKCD', 'PIK3R3', 'PIK3C2G', 'PIK3CB']",0.9541096371653323,0,0,10
179,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.38305611351672575,1.4176284227200724,1.360319078465823,"['ADAMTS2', 'PLOD2', 'PPIB']",0.9541096371653323,0,0,3
180,Type II interferon signaling (IFNG) WP619,0.38305611351672575,1.4176284227200724,1.360319078465823,"['PRKCD', 'ISG15', 'JAK2']",0.9541096371653323,0,0,3
181,Focal Adhesion WP306,0.38944972295991936,1.1043431399735257,1.0414182233190403,"['PRKCG', 'VAV3', 'PXN', 'LAMA3', 'TESK2', 'PIK3R3', 'BRAF', 'PIK3CB', 'LAMC1', 'RHOA', 'MYL12B', 'ACTG1', 'IGF1R', 'CCND2', 'RAP1A', 'COL5A2', 'SOS1']",0.9541096371653323,0,0,17
182,Fatty acid beta-oxidation WP143,0.38984999641455576,1.3086329431438126,1.232723384019732,"['ACSS2', 'ACSL6', 'LPL', 'DECR1']",0.9541096371653323,0,0,4
183,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.38984999641455576,1.3086329431438126,1.232723384019732,"['NFKBIA', 'STAT4', 'JAK2', 'NFKB1']",0.9541096371653323,0,0,4
184,Wnt signaling pathway and pluripotency WP399,0.39160901445595586,1.1601598810187768,1.0876398519587018,"['PRKCG', 'MAP2K4', 'WNT10B', 'PPP2CB', 'CCND2', 'APC', 'WNT5A', 'PRKCD', 'RHOA']",0.9541096371653323,0,0,9
185,Endometrial cancer WP4155,0.39342090118618445,1.191000680735194,1.1110550516389954,"['GADD45B', 'APC', 'PIK3R3', 'BRAF', 'PIK3CB', 'SOS1', 'SOS2']",0.9541096371653323,0,0,7
186,Notch Signaling Pathway Netpath WP61,0.39353760234526963,1.2152575315840621,1.133323236711615,"['JAG1', 'MAML2', 'NOTCH4', 'PSEN2', 'JAK2', 'NFKB1']",0.9541096371653323,0,0,6
187,Biomarkers for pyrimidine metabolism disorders WP4584,0.40426563138769067,1.546317996792895,1.4004740980234573,"['RRM2', 'TK2']",0.9541096371653323,0,0,2
188,BMP Signaling Pathway in Eyelid Development WP3927,0.40426563138769067,1.546317996792895,1.4004740980234573,"['TGFA', 'DKK2']",0.9541096371653323,0,0,2
189,Glioblastoma signaling pathways WP2261,0.4071803429165204,1.142752495192748,1.0267620755308364,"['PRKCG', 'MAP2K4', 'CCND2', 'PRKCD', 'GAB1', 'PIK3C2G', 'BRAF', 'PIK3CB', 'IGF1R']",0.9541096371653323,0,0,9
190,Unfolded protein response WP4925,0.4126763164051255,1.3429092078465001,1.1885978351093536,"['XBP1', 'EIF2AK3', 'EIF2S1']",0.9541096371653323,0,0,3
191,G1 to S cell cycle control WP45,0.41307472931810446,1.1869008068343616,1.0493707644678665,"['CDKN2D', 'CCND2', 'TFDP2', 'RPA1', 'MCM6', 'POLE']",0.9541096371653323,0,0,6
192,Prader-Willi and Angelman Syndrome WP3998,0.41433483198729565,1.2151111974361464,1.0706112177648643,"['CYFIP1', 'SLC45A2', 'CCND2', 'SNRPN', 'BDNF']",0.9541096371653323,0,0,5
193,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.41433483198729565,1.2151111974361464,1.0706112177648643,"['NFKBIA', 'CHP1', 'SOS1', 'NFKB1', 'PDK1']",0.9541096371653323,0,0,5
194,CAMKK2  Pathway WP4874,0.4146165715676799,1.2600644122383253,1.1093621069106818,"['FIS1', 'MAP1LC3A', 'CAMK4', 'CAMKK2']",0.9541096371653323,0,0,4
195,MAPK Signaling Pathway WP382,0.41773611225990176,1.0696954214973473,0.9337428629284006,"['PRKCG', 'MAP2K4', 'BDNF', 'RASGRF2', 'PRKCD', 'PLA2G4C', 'PLA2G4A', 'BRAF', 'RASGRP2', 'NFKB1', 'DUSP7', 'MRAS', 'RAP1A', 'FGF14', 'STMN1', 'RAPGEF2', 'SOS1', 'FGF12', 'SOS2', 'CACNG3', 'MAP4K3', 'FGF22']",0.9541096371653323,0,0,22
196,Alzheimer's disease WP2059,0.42592997820542905,1.1341507720254314,0.9679753600176608,"['ATP5MD', 'PLCB4', 'PSEN2', 'EIF2AK3', 'CHP1', 'LPL', 'CALM3', 'IDE']",0.9541096371653323,0,0,8
197,LTF danger signal response pathway WP4478,0.4265985430101059,2.1259322033898305,1.8111069177970331,['NFKB1'],0.9541096371653323,0,0,1
198,PPAR signaling pathway WP3942,0.4359090638586753,1.1812636906110734,0.9808287889350162,"['FABP5', 'FABP7', 'ME1', 'ACSL6', 'LPL']",0.9541096371653323,0,0,5
199,G13 Signaling Pathway WP524,0.4391520283314365,1.2149650621118013,0.9998064374091096,"['GNA13', 'CYFIP1', 'PIK3CB', 'RHOA']",0.9541096371653323,0,0,4
200,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4391520283314365,1.2149650621118013,0.9998064374091096,"['RAP1A', 'PXN', 'GAB1', 'SOS1']",0.9541096371653323,0,0,4
201,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.4404531095033534,1.0858911754447158,0.8903778675194183,"['YWHAE', 'RYR2', 'YWHAQ', 'MAP2', 'BDNF', 'YWHAB', 'NR3C1', 'SCN3B', 'YWHAZ', 'NFKB1', 'GCK', 'HSP90B1']",0.9541096371653323,0,0,12
202,16p11.2 distal deletion syndrome WP4950,0.44183066884085503,1.2756619144602852,1.0419971005516602,"['JAK2', 'RAB5A', 'SH2B1']",0.9541096371653323,0,0,3
203,Wnt signaling in kidney disease WP4150,0.44183066884085503,1.2756619144602852,1.0419971005516602,"['WNT10B', 'WNT5A', 'RHOA']",0.9541096371653323,0,0,3
204,NAD+ metabolism WP3644,0.4422024520595571,1.417345092718227,1.156535829857028,"['NT5E', 'PARP1']",0.9541096371653323,0,0,2
205,Pyrimidine metabolism and related diseases WP4225,0.4422024520595571,1.417345092718227,1.156535829857028,"['RRM2', 'TK2']",0.9541096371653323,0,0,2
206,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4422024520595571,1.417345092718227,1.156535829857028,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
207,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.442495278058903,1.1154687988564793,0.9094701401488519,"['MAP2K4', 'WNT5A', 'PIK3R3', 'NRG1', 'PIK3CB', 'RHOA', 'NFKB1', 'IGF1R']",0.9541096371653323,0,0,8
208,PI3K-Akt signaling pathway WP4172,0.4433214007035935,1.0519688593862162,0.8557348645011472,"['BDNF', 'LAMA3', 'TGFA', 'PIK3R3', 'PPP2R5A', 'PIK3CB', 'LAMC1', 'EFNA5', 'NFKB1', 'IGF1R', 'HSP90B1', 'PPP2CB', 'GNG3', 'CCND2', 'FGF14', 'COL6A1', 'PKN2', 'GNB5', 'JAK2', 'SOS1', 'FGF12', 'SOS2', 'FGF22']",0.9541096371653323,0,0,23
209,ATM Signaling Network in Development and Disease  WP3878,0.4573005125728247,1.1492457787495176,0.8991865929053603,"['MDC1', 'PRKDC', 'RNF8', 'NFKB1', 'HMGN1']",0.9541096371653323,0,0,5
210,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.4573005125728247,1.1492457787495176,0.8991865929053603,"['ELOVL4', 'SOAT1', 'PMVK', 'LSS', 'TM7SF2']",0.9541096371653323,0,0,5
211,Eukaryotic Transcription Initiation WP405,0.4573005125728247,1.1492457787495176,0.8991865929053603,"['POLR3D', 'POLR2F', 'GTF2H3', 'POLR3K', 'POLR2K']",0.9541096371653323,0,0,5
212,Notch Signaling WP268,0.4633772078895838,1.172976011994003,0.9022693973361171,"['JAG1', 'NOTCH4', 'PSEN2', 'DTX4']",0.9541096371653323,0,0,4
213,p38 MAPK Signaling Pathway WP400,0.4633772078895838,1.172976011994003,0.9022693973361171,"['MAP2K4', 'PLA2G4A', 'MEF2D', 'HMGN1']",0.9541096371653323,0,0,4
214,Parkinson's disease pathway WP2371,0.4633772078895838,1.172976011994003,0.9022693973361171,"['CASP6', 'SYT11', 'PARK7', 'UBE2G2']",0.9541096371653323,0,0,4
215,Aryl Hydrocarbon Receptor Pathway WP2873,0.47040203286321397,1.2148191252060905,0.9161771765234442,"['NCOA1', 'PTGES3', 'CAP2']",0.9541096371653323,0,0,3
216,Oxidative Stress WP408,0.47040203286321397,1.2148191252060905,0.9161771765234442,"['CAT', 'NFKB1', 'SOD1']",0.9541096371653323,0,0,3
217,Sphingolipid pathway WP1422,0.47040203286321397,1.2148191252060905,0.9161771765234442,"['ASAH1', 'SGPL1', 'PLPP1']",0.9541096371653323,0,0,3
218,3q29 copy number variation syndrome WP4906,0.4711012197557259,1.1092280390417035,0.8348963162140886,"['CEP350', 'PXN', 'RNF8', 'PIK3R3', 'NF2', 'DYNLL1']",0.9541096371653323,0,0,6
219,Copper homeostasis WP3286,0.47845609370541153,1.1189130201438333,0.8248524185665511,"['ATP7B', 'SCO1', 'APC', 'ATOX1', 'SOD1']",0.9541096371653323,0,0,5
220,Modulators of TCR signaling and T cell activation WP5072,0.47845609370541153,1.1189130201438333,0.8248524185665511,"['GNA13', 'NFKBIA', 'DGKA', 'MEF2D', 'NFKB1']",0.9541096371653323,0,0,5
221,Cholesterol Biosynthesis Pathway WP197,0.4787588002465142,1.3082141738858157,0.9635760824433045,"['PMVK', 'LSS']",0.9541096371653323,0,0,2
222,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4822652722981689,1.0822946964539886,0.7892752681025115,"['GNA13', 'RAP1A', 'BRAF', 'TTF1', 'JAK2', 'IGF1R', 'MYL12B']",0.9541096371653323,0,0,7
223,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.48697370314282495,1.7006101694915254,1.2236658080197393,['HSD11B2'],0.9541096371653323,0,0,1
224,EDA signaling in hair follicle development WP3930,0.48697370314282495,1.7006101694915254,1.2236658080197393,['EDA'],0.9541096371653323,0,0,1
225,Fluoroacetic acid toxicity WP4966,0.48697370314282495,1.7006101694915254,1.2236658080197393,['ACSS2'],0.9541096371653323,0,0,1
226,Peroxiredoxin 2 induced ovarian failure WP4873,0.48697370314282495,1.7006101694915254,1.2236658080197393,['PARP2'],0.9541096371653323,0,0,1
227,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.48697370314282495,1.7006101694915254,1.2236658080197393,['IGF1R'],0.9541096371653323,0,0,1
228,Pathways in clear cell renal cell carcinoma WP4018,0.49167201791248294,1.0629257493188011,0.7546171364114629,"['PBRM1', 'ZEB1', 'ME1', 'PLOD2', 'VHL', 'ACACB', 'ACACA', 'KCNJ2']",0.9541096371653323,0,0,8
229,Tryptophan metabolism WP465,0.49829115971525734,1.1595074986113683,0.8076789670548707,"['WARS', 'AFMID', 'CAT']",0.9541096371653323,0,0,3
230,IL-4 signaling pathway WP395,0.4993271399819161,1.090135787620492,0.7570925531721195,"['NFKBIA', 'INPP5D', 'JAK2', 'SOS1', 'NFKB1']",0.9541096371653323,0,0,5
231,Synaptic Vesicle Pathway WP2267,0.4993271399819161,1.090135787620492,0.7570925531721195,"['NAPA', 'UNC13A', 'AP2S1', 'PARK7', 'STX1A']",0.9541096371653323,0,0,5
232,EGF/EGFR signaling pathway WP437,0.5056951239035978,1.022885982078484,0.6974254635685375,"['VAV3', 'PRKCD', 'CAMK2A', 'GAB1', 'BRAF', 'NEDD8', 'RAP1A', 'INPP5D', 'STMN1', 'AP2S1', 'RICTOR', 'JAK2', 'SOS1', 'RAB5A', 'SOS2', 'MEF2D']",0.9541096371653323,0,0,16
233,Adipogenesis WP236,0.5070525294016027,1.0369181113366386,0.7042132634302513,"['NCOA1', 'WNT10B', 'NCOA2', 'KLF6', 'SMAD3', 'GADD45B', 'LPL', 'SPOCK1', 'NR3C1', 'MEF2D']",0.9541096371653323,0,0,10
234,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5106206482323911,1.097124824684432,0.7374086826213666,"['RRM2', 'SMAD3', 'SOS1', 'NFKB1']",0.9541096371653323,0,0,4
235,Statin inhibition of cholesterol production WP430,0.5138048899744405,1.2146733863151773,0.8088651917849431,"['SOAT1', 'LPL']",0.9541096371653323,0,0,2
236,Urea cycle and metabolism of amino groups WP497,0.5138048899744405,1.2146733863151773,0.8088651917849431,"['PYCR3', 'SRM']",0.9541096371653323,0,0,2
237,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5198694208933871,1.0627974167233174,0.6952582767575242,"['VAV3', 'BEX3', 'SERBP1', 'NRG1', 'NFKB1']",0.9541096371653323,0,0,5
238,Development of ureteric collection system WP5053,0.5254154772380382,1.1090055786770565,0.7137182223148697,"['GRIP1', 'FRAS1', 'GREB1L']",0.9541096371653323,0,0,3
239,Zinc homeostasis WP3529,0.5254154772380382,1.1090055786770565,0.7137182223148697,"['SLC30A3', 'SLC39A10', 'SLC30A1']",0.9541096371653323,0,0,3
240,Glycogen Synthesis and Degradation WP500,0.5335206593114671,1.0627547554347827,0.6676836296962356,"['PPP2CB', 'PPP2R5A', 'PHKA1', 'CALM3']",0.9541096371653323,0,0,4
241,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.533863848329644,1.026067463205089,0.6439747544809584,"['CDK8', 'RBP4', 'SEC24B', 'LPL', 'SEC24D', 'LSS', 'ACACA']",0.9541096371653323,0,0,7
242,Cell Differentiation - Index WP2029,0.5409956194953608,1.4170621468926554,0.8705637653367317,['MEF2D'],0.9541096371653323,0,0,1
243,Glial Cell Differentiation WP2276,0.5409956194953608,1.4170621468926554,0.8705637653367317,['GAP43'],0.9541096371653323,0,0,1
244,Inflammatory Response Pathway WP453,0.5409956194953608,1.4170621468926554,0.8705637653367317,['LAMC1'],0.9541096371653323,0,0,1
245,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5409956194953608,1.4170621468926554,0.8705637653367317,['TBC1D4'],0.9541096371653323,0,0,1
246,Insulin signaling in adipocytes (normal condition) WP3634,0.5409956194953608,1.4170621468926554,0.8705637653367317,['TBC1D4'],0.9541096371653323,0,0,1
247,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5409956194953608,1.4170621468926554,0.8705637653367317,['NRG3'],0.9541096371653323,0,0,1
248,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5409956194953608,1.4170621468926554,0.8705637653367317,['LPL'],0.9541096371653323,0,0,1
249,Mevalonate pathway WP3963,0.5409956194953608,1.4170621468926554,0.8705637653367317,['PMVK'],0.9541096371653323,0,0,1
250,NAD Biosynthesis II (from tryptophan) WP2485,0.5409956194953608,1.4170621468926554,0.8705637653367317,['AFMID'],0.9541096371653323,0,0,1
251,Sulfation Biotransformation Reaction WP692,0.5409956194953608,1.4170621468926554,0.8705637653367317,['PAPSS1'],0.9541096371653323,0,0,1
252,Valproic acid pathway WP3871,0.5409956194953608,1.4170621468926554,0.8705637653367317,['IVD'],0.9541096371653323,0,0,1
253,Ebstein-Barr virus LMP1 signaling WP262,0.5472535080894747,1.1336047037539574,0.6833858102913496,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
254,Purine metabolism and related disorders WP4224,0.5472535080894747,1.1336047037539574,0.6833858102913496,"['DGUOK', 'APRT']",0.9541096371653323,0,0,2
255,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5517078030090414,1.0627121520706042,0.6320339345586469,"['CAMK4', 'CAMK2A', 'CALM3']",0.9541096371653323,0,0,3
256,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5578050459504533,0.9902912621359223,0.5780783231249124,"['CAP1', 'MAP2K4', 'THRA', 'LPL', 'PIK3R3', 'PIK3C2G', 'RICTOR', 'PIK3CB', 'SLC16A2', 'SOS1', 'SOS2', 'MAP4K3']",0.9541096371653323,0,0,12
257,Senescence and Autophagy in Cancer WP615,0.5704799869560864,0.9855072463768116,0.5531427380960691,"['GABARAPL2', 'GABARAPL1', 'SMAD3', 'MAP1LC3A', 'COL10A1', 'BRAF', 'GABARAP', 'IGF1R']",0.9541096371653323,0,0,8
258,ESC Pluripotency Pathways WP3931,0.5737181160426001,0.9807299040427875,0.5449102956731818,"['WNT10B', 'FGF14', 'APC', 'WNT5A', 'GAB1', 'BRAF', 'SOS1', 'FGF12', 'FGF22']",0.9541096371653323,0,0,9
259,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5771150251453253,1.020122199592668,0.5607751304312449,"['NFKBIA', 'NELFA', 'NFKB1']",0.9541096371653323,0,0,3
260,PDGFR-beta pathway WP3972,0.5771150251453253,1.020122199592668,0.5607751304312449,"['MAP2K4', 'JAK2', 'SOS1']",0.9541096371653323,0,0,3
261,Tumor suppressor activity of SMARCB1 WP4204,0.5771150251453253,1.020122199592668,0.5607751304312449,"['SMARCD1', 'H3F3B', 'H3F3A']",0.9541096371653323,0,0,3
262,TGF-beta Receptor Signaling WP560,0.5776382490839005,1.0000799232736572,0.5488513353727315,"['TGFBR3', 'SMAD3', 'LTBP1', 'NFKB1']",0.9541096371653323,0,0,4
263,Apoptosis Modulation by HSP70 WP384,0.5790525002270964,1.06266960651289,0.5806024313503606,"['CASP6', 'NFKB1']",0.9541096371653323,0,0,2
264,Methionine De Novo and Salvage Pathway WP3580,0.5790525002270964,1.06266960651289,0.5806024313503606,"['TXN', 'SRM']",0.9541096371653323,0,0,2
265,miRNAs involvement in the immune response in sepsis WP4329,0.5790525002270964,1.06266960651289,0.5806024313503606,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
266,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5790525002270964,1.06266960651289,0.5806024313503606,"['BRAF', 'PIK3CB']",0.9541096371653323,0,0,2
267,IL-1 signaling pathway WP195,0.5791470448266426,0.988411616840308,0.5398693084317189,"['NFKBIA', 'MAP2K4', 'PELI2', 'UBE2V1', 'NFKB1']",0.9541096371653323,0,0,5
268,AMP-activated protein kinase (AMPK) signaling WP1403,0.5811101422612359,0.9807692307692307,0.5323762171419324,"['PIK3R3', 'PIK3CB', 'ACACB', 'ACACA', 'SLC2A4RG', 'CAMKK2']",0.9541096371653323,0,0,6
269,ATR Signaling WP3875,0.589332433811267,1.2145278450363197,0.6421996347635662,['RPA1'],0.9541096371653323,0,0,1
270,Blood Clotting Cascade WP272,0.589332433811267,1.2145278450363197,0.6421996347635662,['KLKB1'],0.9541096371653323,0,0,1
271,"Degradation pathway of sphingolipids, including diseases WP4153",0.589332433811267,1.2145278450363197,0.6421996347635662,['GM2A'],0.9541096371653323,0,0,1
272,Farnesoid X receptor pathway WP2879,0.589332433811267,1.2145278450363197,0.6421996347635662,['FKBP5'],0.9541096371653323,0,0,1
273,Heme Biosynthesis WP561,0.589332433811267,1.2145278450363197,0.6421996347635662,['ALAD'],0.9541096371653323,0,0,1
274,IL1 and megakaryocytes in obesity WP2865,0.589332433811267,1.2145278450363197,0.6421996347635662,['NFKB1'],0.9541096371653323,0,0,1
275,Leptin and adiponectin WP3934,0.589332433811267,1.2145278450363197,0.6421996347635662,['ACACA'],0.9541096371653323,0,0,1
276,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.589332433811267,1.2145278450363197,0.6421996347635662,['NFKB1'],0.9541096371653323,0,0,1
277,Vitamin B12 Disorders WP4271,0.589332433811267,1.2145278450363197,0.6421996347635662,['CUBN'],0.9541096371653323,0,0,1
278,Ectoderm Differentiation WP2858,0.5926057859101015,0.9637240068963091,0.5042453418640451,"['AHI1', 'PLCXD3', 'ARHGEF9', 'EDA', 'ELOVL4', 'TSC22D1', 'NARS2', 'ST8SIA4', 'NF2', 'ANKS1B', 'CAP2']",0.9541096371653323,0,0,11
279,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5983075735843562,0.9621871390065461,0.49422773200445785,"['WNT10B', 'CDK8', 'CCND2', 'APC', 'WNT5A', 'DKK2']",0.9541096371653323,0,0,6
280,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5987814353507984,0.9714285714285714,0.498205526291007,"['ACAN', 'THRA', 'COL10A1', 'IGF1R']",0.9541096371653323,0,0,4
281,Endochondral Ossification WP474,0.5987814353507984,0.9714285714285714,0.498205526291007,"['ACAN', 'THRA', 'COL10A1', 'IGF1R']",0.9541096371653323,0,0,4
282,Mesodermal commitment pathway WP2857,0.6035129800501707,0.9548262489078284,0.48217554066972246,"['VAV3', 'CCDC88A', 'SMAD3', 'SESN1', 'RPL38', 'ASCC3', 'JAK2', 'JARID2', 'TEAD1', 'ACACA']",0.9541096371653323,0,0,10
283,Gastric Cancer Network 1 WP2361,0.6091783651139784,1.0000798148295953,0.4956837319483767,"['APC', 'H3F3A']",0.9541096371653323,0,0,2
284,Small cell lung cancer WP4658,0.6150107517789765,0.9442173781410839,0.45899873004037434,"['NFKBIA', 'GADD45B', 'LAMA3', 'PIK3R3', 'LAMC1', 'PIK3CB', 'FHIT', 'NFKB1']",0.9541096371653323,0,0,8
285,Head and Neck Squamous Cell Carcinoma WP4674,0.6151193450472464,0.9442932728647014,0.45886890324070284,"['SESN1', 'GAB1', 'RICTOR', 'PIK3CB', 'NFKB1', 'IGF1R']",0.9541096371653323,0,0,6
286,Glycolysis and Gluconeogenesis WP534,0.625124188253238,0.9444067285207814,0.4436869537748651,"['MDH2', 'MPC2', 'GCK']",0.9541096371653323,0,0,3
287,miRNA regulation of prostate cancer signaling pathways WP3981,0.625124188253238,0.9444067285207814,0.4436869537748651,"['NFKBIA', 'SOS1', 'NFKB1']",0.9541096371653323,0,0,3
288,Apoptosis WP254,0.6315286437218876,0.9270500927643784,0.42608332868610066,"['NFKBIA', 'MAP2K4', 'CRADD', 'CASP6', 'NFKB1', 'IGF1R']",0.9541096371653323,0,0,6
289,15q11.2 copy number variation syndrome WP4940,0.6325820651862598,1.062627118644068,0.4866251153216104,['CYFIP1'],0.9541096371653323,0,0,1
290,Autosomal recessive Osteopetrosis pathways WP4788,0.6325820651862598,1.062627118644068,0.4866251153216104,['NFKB1'],0.9541096371653323,0,0,1
291,Matrix Metalloproteinases WP129,0.6325820651862598,1.062627118644068,0.4866251153216104,['MMP28'],0.9541096371653323,0,0,1
292,Trans-sulfuration pathway WP2333,0.6325820651862598,1.062627118644068,0.4866251153216104,['GCLM'],0.9541096371653323,0,0,1
293,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6376308074320247,0.9444444444444444,0.42499606626525593,"['NFKB1', 'RHOA']",0.9541096371653323,0,0,2
294,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6376308074320247,0.9444444444444444,0.42499606626525593,"['PARP1', 'MDH2']",0.9541096371653323,0,0,2
295,SARS-CoV-2 mitochondrial interactions WP5038,0.6376308074320247,0.9444444444444444,0.42499606626525593,"['ACAD9', 'NFKB1']",0.9541096371653323,0,0,2
296,Splicing factor NOVA regulated synaptic proteins WP4148,0.6390988692934179,0.9187720329024677,0.4113306665262353,"['PLCB4', 'EPB41', 'EFNA5', 'NEO1']",0.9541096371653323,0,0,4
297,Nuclear Receptors Meta-Pathway WP2882,0.6475619690047807,0.9327345364812486,0.4053111976429733,"['NCOA1', 'NCOA2', 'GADD45B', 'PLK2', 'PTGES3', 'TGFA', 'SLC39A10', 'NRG1', 'TXN', 'NR3C1', 'SLC5A3', 'CES4A', 'TGFBR3', 'FGD4', 'DNAJC7', 'ME1', 'GCLM', 'CAP2', 'FKBP5']",0.9541096371653323,0,0,19
298,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.651646203052431,0.9040021985333468,0.38714210344082367,"['WNT10B', 'CCND2', 'APC', 'WNT5A', 'DKK2']",0.9541096371653323,0,0,5
299,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6582355225548558,0.8945223112128147,0.37408249898929746,"['TGFBR3', 'SMAD3', 'LTBP1', 'NFKB1']",0.9541096371653323,0,0,4
300,Cardiac Progenitor Differentiation WP2406,0.6644281190380965,0.8946654288366779,0.3657647965646424,"['MESP1', 'NRG1']",0.9541096371653323,0,0,2
301,Differentiation Pathway WP2848,0.6644281190380965,0.8946654288366779,0.3657647965646424,"['NT5E', 'WNT5A']",0.9541096371653323,0,0,2
302,Glycerolipids and Glycerophospholipids WP4722,0.6644281190380965,0.8946654288366779,0.3657647965646424,"['DGAT2', 'CDIPT']",0.9541096371653323,0,0,2
303,Sphingolipid Metabolism (general overview) WP4725,0.6644281190380965,0.8946654288366779,0.3657647965646424,"['ASAH1', 'SGPL1']",0.9541096371653323,0,0,2
304,White fat cell differentiation WP4149,0.6644281190380965,0.8946654288366779,0.3657647965646424,"['WNT10B', 'NR3C1']",0.9541096371653323,0,0,2
305,Folate Metabolism WP176,0.6692502474963659,0.8791347707001896,0.3530580858704645,"['CAT', 'NFKB1', 'SOD1']",0.9541096371653323,0,0,3
306,Vitamin D-sensitive calcium signaling in depression WP4698,0.6692502474963659,0.8791347707001896,0.3530580858704645,"['CALB1', 'KCNQ3', 'SLC8A1']",0.9541096371653323,0,0,3
307,Hedgehog Signaling Pathway Netpath WP47,0.671279586044399,0.9444821092278719,0.37644181689563916,['SAP18'],0.9541096371653323,0,0,1
308,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.671279586044399,0.9444821092278719,0.37644181689563916,['NFKB1'],0.9541096371653323,0,0,1
309,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.671279586044399,0.9444821092278719,0.37644181689563916,['PMVK'],0.9541096371653323,0,0,1
310,Neuroinflammation WP4919,0.671279586044399,0.9444821092278719,0.37644181689563916,['NFKBIA'],0.9541096371653323,0,0,1
311,Non-homologous end joining WP438,0.671279586044399,0.9444821092278719,0.37644181689563916,['PRKDC'],0.9541096371653323,0,0,1
312,Osteoclast Signaling WP12,0.671279586044399,0.9444821092278719,0.37644181689563916,['ATP6V1G1'],0.9541096371653323,0,0,1
313,Osteopontin Signaling WP1434,0.671279586044399,0.9444821092278719,0.37644181689563916,['NFKB1'],0.9541096371653323,0,0,1
314,T-cell receptor (TCR) signaling pathway WP69,0.6782101356509765,0.8788881069669247,0.34127058597919335,"['VAV3', 'NFKBIA', 'DBNL', 'PRKCD', 'SOS1', 'NFKB1']",0.9541096371653323,0,0,6
315,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6847565747848654,0.8669654129496802,0.3283127527223767,"['NFKBIA', 'STMN1', 'PXN', 'SOS1', 'NFKB1']",0.9541096371653323,0,0,5
316,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6896032738649107,0.8498643147896879,0.3158425644456151,"['H3F3B', 'H3F3A']",0.9541096371653323,0,0,2
317,Estrogen signaling pathway WP712,0.6896032738649107,0.8498643147896879,0.3158425644456151,"['BRAF', 'NFKB1']",0.9541096371653323,0,0,2
318,Sphingolipid Metabolism (integrated pathway) WP4726,0.6896032738649107,0.8498643147896879,0.3158425644456151,"['ASAH1', 'SGPL1']",0.9541096371653323,0,0,2
319,Type 2 papillary renal cell carcinoma WP4241,0.6898375314649197,0.8497623896809233,0.31551607063268566,"['PRCC', 'TGFA', 'VHL']",0.9541096371653323,0,0,3
320,Insulin Signaling WP481,0.6940121547183883,0.8938008495932033,0.326474886501402,"['CAP1', 'MAP2K4', 'XBP1', 'PRKCD', 'GAB1', 'PIK3R3', 'PIK3C2G', 'PIK3CB', 'PTPRF', 'IGF1R', 'TBC1D4', 'SOS1', 'SOS2', 'MAP4K3']",0.9541096371653323,0,0,14
321,NRF2 pathway WP2884,0.6961598782613448,0.8711660728009502,0.3155153868536792,"['ME1', 'TGFA', 'SLC39A10', 'NRG1', 'TXN', 'GCLM', 'SLC5A3', 'CES4A']",0.9541096371653323,0,0,8
322,Cysteine and methionine catabolism WP4504,0.7059038237655691,0.8499661016949153,0.2960230300946271,['GSS'],0.9541096371653323,0,0,1
323,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7059038237655691,0.8499661016949153,0.2960230300946271,['NFKB1'],0.9541096371653323,0,0,1
324,FOXA2 pathway WP5066,0.7059038237655691,0.8499661016949153,0.2960230300946271,['ACACA'],0.9541096371653323,0,0,1
325,Homologous recombination WP186,0.7059038237655691,0.8499661016949153,0.2960230300946271,['RPA1'],0.9541096371653323,0,0,1
326,Hypertrophy Model WP516,0.7059038237655691,0.8499661016949153,0.2960230300946271,['ZEB1'],0.9541096371653323,0,0,1
327,NO metabolism in cystic fibrosis WP4947,0.7059038237655691,0.8499661016949153,0.2960230300946271,['PRMT8'],0.9541096371653323,0,0,1
328,Apoptosis Modulation and Signaling WP1772,0.7071171569284251,0.8494557823129252,0.29438647584965727,"['NFKBIA', 'TNFRSF6B', 'CRADD', 'CASP6', 'BIRC6', 'NFKB1']",0.9541096371653323,0,0,6
329,ATM Signaling Pathway WP2516,0.7094455539945039,0.8222850009854806,0.28226702535410203,"['NFKBIA', 'MDC1', 'CRADD']",0.9541096371653323,0,0,3
330,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7094455539945039,0.8222850009854806,0.28226702535410203,"['NFKBIA', 'CAMK2A', 'NFKB1']",0.9541096371653323,0,0,3
331,Cannabinoid receptor signaling WP3869,0.7132006387425924,0.809329973509078,0.2735474589610281,"['ADCY1', 'ADCY7']",0.9541096371653323,0,0,2
332,Gastric Cancer Network 2 WP2363,0.7132006387425924,0.809329973509078,0.2735474589610281,"['RFC3', 'S100A6']",0.9541096371653323,0,0,2
333,Signal transduction through IL1R WP4496,0.7132006387425924,0.809329973509078,0.2735474589610281,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
334,Toll-like Receptor Signaling Pathway WP75,0.7156727241956429,0.8328334732941443,0.2786097020275928,"['NFKBIA', 'MAP2K4', 'PIK3R3', 'PIK3CB', 'NFKB1']",0.9541096371653323,0,0,5
335,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7277606266826754,0.8090709109730849,0.2571090576432376,"['BDNF', 'CAMK4', 'PIK3R3', 'PIK3CB']",0.9541096371653323,0,0,4
336,Wnt Signaling Pathway WP363,0.7277606266826754,0.8090709109730849,0.2571090576432376,"['PRKCG', 'APC', 'PIP5K1B', 'RHOA']",0.9541096371653323,0,0,4
337,"GPCRs, Other WP117",0.7280853679692213,0.796524949083503,0.25276681703083226,"['CCKBR', 'ADGRF5', 'MCHR2']",0.9541096371653323,0,0,3
338,Netrin-UNC5B signaling pathway WP4747,0.7280853679692213,0.796524949083503,0.25276681703083226,"['INPP5D', 'NEO1', 'RHOA']",0.9541096371653323,0,0,3
339,TGF-beta Signaling Pathway WP366,0.7336759476822213,0.8490450204638472,0.2629389150740434,"['TGFBR3', 'MAP2K4', 'KLF6', 'SMAD3', 'ZEB1', 'CITED1', 'WWP1', 'SOS1', 'RHOA', 'PDK1']",0.9541096371653323,0,0,10
340,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7342054022686865,0.8219223173140224,0.25394642048420846,"['THRA', 'TBC1D4', 'TTF1', 'SLC16A2', 'SOS1', 'MGLL']",0.9541096371653323,0,0,6
341,Peptide GPCRs WP24,0.7352732125638138,0.7724805723448871,0.23754791948892204,"['NPY5R', 'CCKBR']",0.9541096371653323,0,0,2
342,Airway smooth muscle cell contraction WP4962,0.736883269627192,0.7726348228043143,0.23590533393709634,['RHOA'],0.9541096371653323,0,0,1
343,Cancer immunotherapy by PD-1 blockade WP4585,0.736883269627192,0.7726348228043143,0.23590533393709634,['NFKB1'],0.9541096371653323,0,0,1
344,Canonical and non-canonical TGF-B signaling WP3874,0.736883269627192,0.7726348228043143,0.23590533393709634,['SMAD3'],0.9541096371653323,0,0,1
345,Cell Differentiation - Index expanded WP2023,0.736883269627192,0.7726348228043143,0.23590533393709634,['MEF2D'],0.9541096371653323,0,0,1
346,Galanin receptor pathway WP4970,0.736883269627192,0.7726348228043143,0.23590533393709634,['PRKCD'],0.9541096371653323,0,0,1
347,NOTCH1 regulation of endothelial cell calcification WP3413,0.736883269627192,0.7726348228043143,0.23590533393709634,['JAG1'],0.9541096371653323,0,0,1
348,Overview of nanoparticle effects WP3287,0.736883269627192,0.7726348228043143,0.23590533393709634,['LAMA3'],0.9541096371653323,0,0,1
349,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.736883269627192,0.7726348228043143,0.23590533393709634,['SMAD3'],0.9541096371653323,0,0,1
350,Androgen receptor signaling pathway WP138,0.7387980789927324,0.8256277891233643,0.2499428214343195,"['NCOA1', 'NCOA2', 'SMAD3', 'DSTN', 'PARK7', 'RHOA', 'PLPP1']",0.9541096371653323,0,0,7
351,Regulation of toll-like receptor signaling pathway WP1449,0.7387980789927324,0.8256277891233643,0.2499428214343195,"['NFKBIA', 'MAP2K4', 'PELI2', 'TIFA', 'PIK3R3', 'PIK3CB', 'NFKB1']",0.9541096371653323,0,0,7
352,Kit receptor signaling pathway WP304,0.7433836681733521,0.7901921132457027,0.2343259322975958,"['INPP5D', 'MITF', 'JAK2', 'SOS1']",0.9541096371653323,0,0,4
353,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7433836681733521,0.7901921132457027,0.2343259322975958,"['NFKBIA', 'PIN1', 'ISG15', 'NFKB1']",0.9541096371653323,0,0,4
354,p53 transcriptional gene network WP4963,0.7433836681733521,0.7901921132457027,0.2343259322975958,"['SIVA1', 'SESN1', 'FANCC', 'ISG15']",0.9541096371653323,0,0,4
355,Ebola Virus Pathway on Host WP4217,0.7547791193019379,0.8183579002659138,0.2302287342656289,"['PIK3R3', 'PIK3CB', 'EIF2S1', 'RAB5A', 'NFKB1', 'RHOA', 'IGF1R', 'ACTG1']",0.9541096371653323,0,0,8
356,Glycosylation and related congenital defects WP4521,0.7558803203727289,0.7388354669341042,0.2067795236161314,"['DPM2', 'DPM3']",0.9541096371653323,0,0,2
357,IL17 signaling pathway WP2112,0.7558803203727289,0.7388354669341042,0.2067795236161314,"['JAK2', 'NFKB1']",0.9541096371653323,0,0,2
358,Lung fibrosis WP3624,0.7558803203727289,0.7388354669341042,0.2067795236161314,"['FAM13A', 'TGFA']",0.9541096371653323,0,0,2
359,Trans-sulfuration and one-carbon metabolism WP2525,0.7558803203727289,0.7388354669341042,0.2067795236161314,"['GSS', 'GCLM']",0.9541096371653323,0,0,2
360,Amino Acid metabolism WP3925,0.7594664642191498,0.796109693877551,0.2190409150225793,"['WARS', 'MDH2', 'IDH1', 'GSS', 'GCLM', 'SRM']",0.9541096371653323,0,0,6
361,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7624072068774796,0.8619278496948165,0.23381902388340928,"['RAB2A', 'LAMA3', 'PPP2R5A', 'PIK3CB', 'LAMC1', 'EFNA5', 'ACACA', 'IGF1R', 'HSP90B1', 'PPP2CB', 'TBC1D1', 'GNG3', 'FGF14', 'RAB14', 'COL5A2', 'JAK2', 'SOS1', 'FGF12', 'FGF22']",0.9541096371653323,0,0,19
362,"GPCRs, Class B Secretin-like WP334",0.7646013666680174,0.7081920903954803,0.19007923175812003,['GLP2R'],0.9541096371653323,0,0,1
363,Omega-3/Omega-6 FA synthesis WP4723,0.7646013666680174,0.7081920903954803,0.19007923175812003,['PLA2G4A'],0.9541096371653323,0,0,1
364,Phytochemical activity on NRF2 transcriptional activation WP3,0.7646013666680174,0.7081920903954803,0.19007923175812003,['GCLM'],0.9541096371653323,0,0,1
365,Transcription co-factors SKI and SKIL protein partners WP4533,0.7646013666680174,0.7081920903954803,0.19007923175812003,['TEAD1'],0.9541096371653323,0,0,1
366,Tryptophan catabolism leading to NAD+ production WP4210,0.7646013666680174,0.7081920903954803,0.19007923175812003,['AFMID'],0.9541096371653323,0,0,1
367,DNA IR-damage and cellular response via ATR WP4016,0.7714159429589355,0.7837990580847723,0.20341746166613864,"['MDC1', 'FEN1', 'PARP1', 'PRKDC', 'RPA1', 'CLSPN']",0.9541096371653323,0,0,6
368,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7725627105334769,0.754951690821256,0.19480931578812383,"['MDC1', 'PARP1', 'PRKDC', 'RNF8']",0.9541096371653323,0,0,4
369,Endothelin Pathways WP2197,0.775085696249419,0.7079941203075532,0.18038393135686934,"['RIIAD1', 'GNB5']",0.9541096371653323,0,0,2
370,Glycerophospholipid Biosynthetic Pathway WP2533,0.775085696249419,0.7079941203075532,0.18038393135686934,"['PIK3CB', 'CDIPT']",0.9541096371653323,0,0,2
371,Lipid Metabolism Pathway WP3965,0.775085696249419,0.7079941203075532,0.18038393135686934,"['ACSS2', 'ACACA']",0.9541096371653323,0,0,2
372,Nanoparticle-mediated activation of receptor signaling WP2643,0.775085696249419,0.7079941203075532,0.18038393135686934,"['PXN', 'SOS1']",0.9541096371653323,0,0,2
373,Nuclear receptors WP170,0.775085696249419,0.7079941203075532,0.18038393135686934,"['THRA', 'NR3C1']",0.9541096371653323,0,0,2
374,The influence of laminopathies on Wnt signaling WP4844,0.775085696249419,0.7079941203075532,0.18038393135686934,"['WNT10B', 'APC']",0.9541096371653323,0,0,2
375,Aryl Hydrocarbon Receptor Netpath WP2586,0.7783766242561778,0.7280768111725342,0.18241584379730658,"['KLF6', 'LPL', 'NFKB1']",0.9541096371653323,0,0,3
376,Thermogenesis WP4321,0.7858771984499584,0.7896204296305684,0.19026278123625637,"['SMARCD1', 'ACSL6', 'ADCY1', 'SOS1', 'SOS2', 'ADCY7', 'MGLL', 'ACTG1']",0.9541096371653323,0,0,8
377,Eicosanoid Synthesis WP167,0.7894012433684654,0.6536636245110822,0.15457872734346,['PLA2G4A'],0.9541096371653323,0,0,1
378,Kennedy pathway from sphingolipids WP3933,0.7894012433684654,0.6536636245110822,0.15457872734346,['SGPL1'],0.9541096371653323,0,0,1
379,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7894012433684654,0.6536636245110822,0.15457872734346,['RHOA'],0.9541096371653323,0,0,1
380,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7894012433684654,0.6536636245110822,0.15457872734346,['NFKB1'],0.9541096371653323,0,0,1
381,Riboflavin and CoQ disorders WP5037,0.7894012433684654,0.6536636245110822,0.15457872734346,['PDSS2'],0.9541096371653323,0,0,1
382,Type II diabetes mellitus WP1584,0.7894012433684654,0.6536636245110822,0.15457872734346,['PRKCD'],0.9541096371653323,0,0,1
383,GABA receptor Signaling WP4159,0.7929558997460399,0.6796200814111262,0.15766347972597702,"['GABRA3', 'AP2S1']",0.9541096371653323,0,0,2
384,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7929558997460399,0.6796200814111262,0.15766347972597702,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
385,One-carbon metabolism and related pathways WP3940,0.7933428676771068,0.707795881421136,0.16385459294069327,"['GSS', 'GCLM', 'SOD1']",0.9541096371653323,0,0,3
386,Vitamin D Receptor Pathway WP2877,0.7939726666620802,0.7602802314955833,0.175401395977226,"['CDKN2D', 'TPM1', 'S100A6', 'EFNA5', 'SLC8A1', 'CD200']",0.9541096371653323,0,0,6
387,MECP2 and Associated Rett Syndrome WP3584,0.7952337968445532,0.7448089973403939,0.17064998463128433,"['BDNF', 'CAMK2A', 'NREP', 'IGF1R', 'FKBP5']",0.9541096371653323,0,0,5
388,Histone Modifications WP2369,0.807456416437999,0.6886112181427864,0.14727066367064845,"['SETD5', 'H3F3B', 'H3F3A']",0.9541096371653323,0,0,3
389,ERK Pathway in Huntington's Disease WP3853,0.8115899491703781,0.6069249394673123,0.12670168379057611,['BDNF'],0.9541096371653323,0,0,1
390,Kynurenine Pathway and links to Cellular Senescence WP5044,0.8115899491703781,0.6069249394673123,0.12670168379057611,['AFMID'],0.9541096371653323,0,0,1
391,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8115899491703781,0.6069249394673123,0.12670168379057611,['PXN'],0.9541096371653323,0,0,1
392,Overview of interferons-mediated signaling pathway WP4558,0.8115899491703781,0.6069249394673123,0.12670168379057611,['JAK2'],0.9541096371653323,0,0,1
393,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.8115899491703781,0.6069249394673123,0.12670168379057611,['IDH1'],0.9541096371653323,0,0,1
394,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8175086073501727,0.7194460127435505,0.14496394510244848,"['SMAD3', 'GADD45B', 'APC', 'BRAF', 'RHOA']",0.9541096371653323,0,0,5
395,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8230138484973697,0.6931011535048802,0.1350038032640588,"['RYR2', 'CACNG3', 'SLC8A1', 'ACTG1']",0.9541096371653323,0,0,4
396,Vitamin A and carotenoid metabolism WP716,0.8249635967474924,0.6291773455952561,0.12106379994321001,"['RBP4', 'LPL']",0.9541096371653323,0,0,2
397,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8314422461900196,0.5664180790960452,0.10455706177762492,['PLA2G4A'],0.9541096371653323,0,0,1
398,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8314422461900196,0.5664180790960452,0.10455706177762492,['JARID2'],0.9541096371653323,0,0,1
399,Transcription factor regulation in adipogenesis WP3599,0.8314422461900196,0.5664180790960452,0.10455706177762492,['NR3C1'],0.9541096371653323,0,0,1
400,Energy Metabolism WP1541,0.8332486989213744,0.6531933782442947,0.11915757614293189,"['NCOA1', 'CAMK4', 'MEF2D']",0.9541096371653323,0,0,3
401,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8332486989213744,0.6531933782442947,0.11915757614293189,"['MAP1LC3A', 'ATG101', 'ACACA']",0.9541096371653323,0,0,3
402,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8332486989213744,0.6531933782442947,0.11915757614293189,"['WNT10B', 'SMAD3', 'APC']",0.9541096371653323,0,0,3
403,Acute viral myocarditis WP4298,0.8340744110411064,0.6791847826086956,0.12322630087873575,"['PARP1', 'CASP6', 'ABL2', 'SOS1']",0.9541096371653323,0,0,4
404,Neural Crest Differentiation WP2064,0.8340744110411064,0.6791847826086956,0.12322630087873575,"['NOTCH4', 'MITF', 'NFKB1', 'CDH7']",0.9541096371653323,0,0,4
405,Male infertility WP4673,0.8403458943769565,0.7243603579670923,0.12599646692162875,"['DDX4', 'UBE2B', 'PARP1', 'MSH5', 'CAT', 'HORMAD1', 'CHD2']",0.9541096371653323,0,0,7
406,Metapathway biotransformation Phase I and II WP702,0.8403458943769565,0.7243603579670923,0.12599646692162875,"['AKR7A2', 'NAA20', 'GSS', 'KCNAB3', 'HS3ST4', 'HS3ST1', 'NAA80']",0.9541096371653323,0,0,7
407,DNA damage response WP707,0.8445515131635316,0.6658141517476556,0.11248899877610109,"['CCND2', 'GADD45B', 'PRKDC', 'SESN1']",0.9541096371653323,0,0,4
408,Proteasome Degradation WP183,0.8445515131635316,0.6658141517476556,0.11248899877610109,"['PSMD8', 'PSMD7', 'UBE2B', 'PSMA7']",0.9541096371653323,0,0,4
409,Nanomaterial induced apoptosis WP2507,0.8492040020083043,0.5309745762711865,0.08679089351593866,['CASP6'],0.9541096371653323,0,0,1
410,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.8492040020083043,0.5309745762711865,0.08679089351593866,['APC'],0.9541096371653323,0,0,1
411,IL-2 signaling pathway WP49,0.8524487657651885,0.5856922285126094,0.0935011785693791,"['CCND2', 'SOS1']",0.9541096371653323,0,0,2
412,IL-5 signaling pathway WP127,0.8524487657651885,0.5856922285126094,0.0935011785693791,"['JAK2', 'SOS1']",0.9541096371653323,0,0,2
413,Oxidative Damage WP3941,0.8524487657651885,0.5856922285126094,0.0935011785693791,"['MAP2K4', 'NFKB1']",0.9541096371653323,0,0,2
414,Phosphodiesterases in neuronal function WP4222,0.8560099635067829,0.6212309373602901,0.09658480109271131,"['PDE4C', 'ADCY1', 'ADCY7']",0.9541096371653323,0,0,3
415,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8560099635067829,0.6212309373602901,0.09658480109271131,"['NFKBIA', 'MAP2K4', 'NFKB1']",0.9541096371653323,0,0,3
416,Hippo-Merlin Signaling Dysregulation WP4541,0.8595605432383426,0.6879757308328737,0.10411413065109118,"['PLCB4', 'NF2', 'TEAD1', 'CDH18', 'IGF1R', 'CDH7']",0.9541096371653323,0,0,6
417,miRNA regulation of DNA damage response WP1530,0.8638361711122728,0.6405865463494668,0.09376402679979236,"['CCND2', 'GADD45B', 'PRKDC', 'SESN1']",0.9541096371653323,0,0,4
418,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8646619714621353,0.5661239258254184,0.08232383507684642,"['NFKBIA', 'NFKB1']",0.9541096371653323,0,0,2
419,Immune response to tuberculosis WP4197,0.8650952264339766,0.49970089730807576,0.07241450020037381,['JAK2'],0.9541096371653323,0,0,1
420,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8650952264339766,0.49970089730807576,0.07241450020037381,['GCLM'],0.9541096371653323,0,0,1
421,Toll-like Receptor Signaling related to MyD88 WP3858,0.8650952264339766,0.49970089730807576,0.07241450020037381,['NFKB1'],0.9541096371653323,0,0,1
422,TYROBP causal network in microglia WP3945,0.8650952264339766,0.49970089730807576,0.07241450020037381,['SFT2D2'],0.9541096371653323,0,0,1
423,Exercise-induced Circadian Regulation WP410,0.8663365533950045,0.6063912326641451,0.08700611534815399,"['DNAJA1', 'PPP2CB', 'CRY2']",0.9541096371653323,0,0,3
424,RANKL/RANK signaling pathway WP2018,0.8663365533950045,0.6063912326641451,0.08700611534815399,"['NFKBIA', 'MITF', 'NFKB1']",0.9541096371653323,0,0,3
425,Integrin-mediated Cell Adhesion WP185,0.8673534891928008,0.6787482993197279,0.09659176771580896,"['VAV3', 'RAP1A', 'CAPN7', 'PXN', 'BRAF', 'SOS1']",0.9541096371653323,0,0,6
426,IL-18 signaling pathway WP4754,0.8684844133171613,0.7657529501991539,0.10797548492576552,"['NRN1', 'PARP1', 'EPB41', 'HSPB8', 'PRKCD', 'PRCC', 'NDUFC1', 'ACACB', 'NFKB1', 'NFKBIA', 'ALS2', 'CCDC9', 'NACA', 'TMSB4X', 'STMN1']",0.9541096371653323,0,0,15
427,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.879312789621736,0.4719020715630885,0.06069349498020822,['MAP1LC3A'],0.9614915550069449,0,0,1
428,Mitochondrial Gene Expression WP391,0.879312789621736,0.4719020715630885,0.06069349498020822,['CAMK4'],0.9614915550069449,0,0,1
429,1q21.1 copy number variation syndrome WP4905,0.8920328538519988,0.44702943800178413,0.051074148347130255,['AFDN'],0.9634931177801106,0,0,1
430,Complement and Coagulation Cascades WP558,0.8920328538519988,0.44702943800178413,0.051074148347130255,['KLKB1'],0.9634931177801106,0,0,1
431,NRF2-ARE regulation WP4357,0.8920328538519988,0.44702943800178413,0.051074148347130255,['GCLM'],0.9634931177801106,0,0,1
432,Signal Transduction of S1P Receptor WP26,0.8920328538519988,0.44702943800178413,0.051074148347130255,['ASAH1'],0.9634931177801106,0,0,1
433,Urea cycle and associated pathways WP4595,0.8920328538519988,0.44702943800178413,0.051074148347130255,['MDH2'],0.9634931177801106,0,0,1
434,Cardiac Hypertrophic Response WP2795,0.8934957545225812,0.5658293731613487,0.06372013696475856,"['MAP2K4', 'NRG1', 'NFKB1']",0.9634931177801106,0,0,3
435,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9032811402253408,0.5851293103448276,0.05952019240320799,"['PSMD8', 'PSMD7', 'TUBB2A', 'UBE2G2']",0.9651516770595991,0,0,4
436,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9034130508479203,0.4246440677966102,0.043133395077766645,['BDNF'],0.9651516770595991,0,0,1
437,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9047716792569667,0.49936148136323727,0.04997242935763772,"['SMAD3', 'NFKB1']",0.9651516770595991,0,0,2
438,Spinal Cord Injury WP2431,0.9073730422429729,0.6058560745848305,0.058890192533054435,"['ACAN', 'GAP43', 'BDNF', 'NCAN', 'RHOA']",0.9651516770595991,0,0,5
439,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.90873845778743,0.5416648611171296,0.05183621756069062,"['INF2', 'JAG1', 'YWHAQ']",0.9651516770595991,0,0,3
440,7-oxo-C and 7beta-HC pathways WP5064,0.9135944293534239,0.4043906376109766,0.03654419052659936,['HSD11B2'],0.9651516770595991,0,0,1
441,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9135944293534239,0.4043906376109766,0.03654419052659936,['THRA'],0.9651516770595991,0,0,1
442,Nanoparticle triggered autophagic cell death WP2509,0.9135944293534239,0.4043906376109766,0.03654419052659936,['MAP1LC3A'],0.9651516770595991,0,0,1
443,Physiological and pathological hypertrophy of the heart WP1528,0.9135944293534239,0.4043906376109766,0.03654419052659936,['RHOA'],0.9651516770595991,0,0,1
444,TNF-alpha signaling pathway WP231,0.9239103436862965,0.5808181928238175,0.04596609273928929,"['NFKBIA', 'MAP2K4', 'TXN', 'SOS1', 'NFKB1']",0.9738514433450152,0,0,5
445,Metabolic reprogramming in colon cancer WP4290,0.9272397743027441,0.4587626975686677,0.0346563520521431,"['MDH2', 'IDH2']",0.9751645266824364,0,0,2
446,Pre-implantation embryo WP3527,0.9308522902624271,0.3691672807663965,0.026452560183222396,['NR3C2'],0.9767687709480176,0,0,1
447,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9334327153470577,0.49902160456850764,0.034375800077759935,"['STMN1', 'RICTOR', 'JAK2']",0.9772852590210807,0,0,3
448,Ethanol effects on histone modifications WP3996,0.9381427509089142,0.3537570621468927,0.0225885045516939,['ACSS2'],0.9778414419273315,0,0,1
449,Fluoropyrimidine Activity WP1601,0.9381427509089142,0.3537570621468927,0.0225885045516939,['RRM2'],0.9778414419273315,0,0,1
450,Intraflagellar transport proteins binding to dynein WP4532,0.9504999237316795,0.32649282920469364,0.016575125875267636,['DYNLL1'],0.9863280805020531,0,0,1
451,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9504999237316795,0.32649282920469364,0.016575125875267636,['NFKBIA'],0.9863280805020531,0,0,1
452,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9557199209579418,0.31437539234149403,0.014238180530355683,['BRAF'],0.9895507146201699,0,0,1
453,Interferon type I signaling pathways WP585,0.9580193068149527,0.3945599697074879,0.016921630713050327,"['RAP1A', 'STAT4']",0.9897418004180968,0,0,2
454,Autophagy WP4923,0.9603897538724587,0.3031234866828087,0.012251064086812799,['ATG101'],0.9899507237731309,0,0,1
455,Bladder cancer WP2828,0.9645673718815121,0.29264757451782586,0.01055743609655376,['BRAF'],0.9899507237731309,0,0,1
456,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9645673718815121,0.29264757451782586,0.01055743609655376,['TGFA'],0.9899507237731309,0,0,1
457,Genotoxicity pathway WP4286,0.968271739036516,0.3687393074154917,0.011889080421584342,"['RPS27', 'RAPGEF2']",0.9906998214074416,0,0,2
458,Hedgehog Signaling Pathway WP4249,0.9716479017649908,0.27372334609076,0.007872770970250548,['CCND2'],0.9906998214074416,0,0,1
459,Target Of Rapamycin (TOR) Signaling WP1471,0.9716479017649908,0.27372334609076,0.007872770970250548,['RICTOR'],0.9906998214074416,0,0,1
460,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.974638711127639,0.26514830508474574,0.006811243501249527,['MAP2K4'],0.9915889495820326,0,0,1
461,Pathways affected in adenoid cystic carcinoma WP3651,0.9802282717087256,0.3324553702077846,0.006639068623868196,"['PRKDC', 'DTX4']",0.992781938411154,0,0,2
462,Integrated Cancer Pathway WP1971,0.983763767312943,0.2356120527306968,0.0038568478737417583,['SMAD3'],0.992781938411154,0,0,1
463,Interleukin-11 Signaling Pathway WP2332,0.9854769933954217,0.22922583600549704,0.003353458856787362,['JAK2'],0.992781938411154,0,0,1
464,Integrated breast cancer pathway WP1984,0.9870848749148209,0.48131852319203927,0.006256780016839984,"['FER', 'RAP1A', 'RALGAPA1', 'ZMYND8', 'BRAF', 'FAU', 'NFKB1']",0.992781938411154,0,0,7
465,"GPCRs, Class A Rhodopsin-like WP455",0.9876108095915483,0.3578784314850406,0.00446151875705037,"['MAS1', 'CCKBR', 'NPY5R']",0.992781938411154,0,0,3
466,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9896066695403785,0.21198305084745764,0.0022147391983596875,['MAP2K4'],0.992781938411154,0,0,1
467,Circadian rhythm related genes WP3594,0.990660609482925,0.48295056442195405,0.0045316584796221355,"['PRKCG', 'NCOA2', 'PRKDC', 'CRY2', 'DYRK1A', 'ADCY1', 'CARTPT', 'RPS27A']",0.992781938411154,0,0,8
468,22q11.2 copy number variation syndrome WP4657,0.998856955495718,0.21144843962008142,0.00024183321625681836,"['RANBP1', 'AIFM3']",0.998856955495718,0,0,2
